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CHAPTER I
INTRODUCTION
Introduction to the Problem
In January 1987, a Conrail traincollided with an
Amtrak train, resulting in16 deaths and 170 injuries.
The subsequent investigationdetermined that the
engineer's smoking marijuanaprior to the collisionwas a
significantcontributing factor to the accident(Taggart,
1989).A poll of callers toa national cocaine hotline
reported 75 percent of therespondents used drugson the
job, while 92 percentagreed drugs interfered with their
job performance (Walsh& Yohay, 1987).A Portland, Oregon
distributing company found50 percent of its truck drivers
tested positive for drugsafter implementing a drug test-
ing requirement (Oregon BusinessCouncil, 1989).These
are but a few examples of what hasbeen recognized as a
major problem facing Americanbusinesses today: workplace
drug abuse.
The impact of drug abuse inthe workplace has been
characterized as "throwing sand inthe nation's industrial
engine" (Sanoff & Hogue,1985, p. 55).Estimates of the2
annual economic loss attributableto drug use have ranged
from $60 to $100 billion(Williams, 1986).At the indi-
vidual level, research hasfound employees using illicit
drugs:1) are three timesmore likely to be late to work,
2) have absenteeism rates16 times higher than theaverage
employee, and 3) use three times thenormal level of sick
benefits (Backer, 1987;Banta & Tennant, 1989; Cowan,
1987).As evidence of the pervasivenessand costs of
employee drug abuse became known,the business community
realized that the problemcould not be ignored (Campbell &
Graham, 1988).
Spurred by the financial implicationsof employee
drug use and by new federalgovernment regulations, many
companies have developeda variety of programs to combat
workplace substance abuse.Recently, attention has been
directed at the importance ofcountering the workplace
drug abuse problem ina comprehensive fashion.Rather
than relying on one specificstrategy, the emphasis has
shifted to a multi-faceted approachutilizing different
strategies within a comprehensivedrug prevention frame-
work.During the past tenyears, several principle anti-
drug strategies have proliferated,notably employee assis-
tance programs, the adoption ofworkplace drug policies,
and the implementation of drugscreening and detection
programs.
Employee assistanceprograms (EAPs) have tradition-
ally provided services for theemployee whose job3
performance was being negativelyaffected by a personal
problem (Campbell & Graham,1988).Although company spon-
sored employee assistance servicesdate back to the occu-
pational alcoholismprograms of the 1940s, the current
comprehensive approach developed withthe realization that
employee productivity andperformance could be adversely
affected by a range of factors (Masi,1984).The ration-
ale for aiding employees withsubstance abuse problems was
based on economics.Kinnan (1990) noted that it costs
less to assist an employee thanto recruit, hire, and
train a replacement.
A more recent strategy in combattingemployee drug
abuse has been the developmentof the workplace drug poli-
cy.Such policies generally articulateda company's stand
against illegal drugs andbanned the use of controlled
substances in the workplace (Kinnan,1990).The prolifer-
ation of company drug policieshas been attributed to
federal government legislation mandatingpolicy implemen-
tation.Specifically, the 1988 DrugFree Workplace Act
required all federal contractorsand funding recipients to
adopt a worksite drug policy (Kiell,1990).
The most controversial of theprinciple workplace
anti-drug strategies implementedby many organizations has
been the use of drug testing.As with the drug policies,
the prevalence of drug detectionprograms was promoted by
federal government regulations.In 1986, a Presidential
Executive Order required randomdrug testing for certain4
categories of federalemployees (Axel, 1990).By 1988,
regulations issued by theTransportation Department and
the Department of Defensehad extended drug testingman-
dates into the privatesector (Axel, 1990).The rise in
workplace drug testing hasbeen tremendous.Less than
five percent of theFortune 500 companies utilizedsome
form of drug testing in1982 (Vodanovich & Reyna,1988).
By 1990, nationalsurveys were reporting over 50percent
of the large companiessurveyed were administeringdrug
tests (Greenberg, 1990).
National surveys havedocumented the rise in the
prevalence of anti-druginitiatives within the business
community, especiallythe tremendous increase inthe use
of drug testing.The utility of this researchhas been
limited in part becausethe focus was large corporations
representing numerous industries(e.g., manufacturing,
finance/insurance, retail,utilities) located throughout
the country.As a result, it has beendifficult to apply
information from the nationalresearch to specific busi-
ness sectors or specific geographicalareas.Comparisons
of business organizations'anti-drug efforts withina
particular state or specificindustrial sector have not
been possible with thepresent base of research informa-
tion.Given the limitations inthe research, attention
needs to be directed atdeveloping information regarding
workplace drug abuse endeavorsby specific categories of
businesses.5
Purpose of the Study
The purpose of this studywas to identify and exam-
ine the workplace initiativestaken by Oregon manufactur-
ers to reduce the threat ofemployee drug abuse.
The objectives of theresearch were:
1)To review existing literaturepertaining to
organizational programs designedto control
illicit drug use in theworkplace.
2)To determine if thereare differences between
companies with drug policiesand/or drug testing
programs based on company size.
3)To determine if thereare differences between
companies with drug policiesand/or drug testing
programs based on industry classification.
4)To identify contributingfactors that supported
the decision to implementor not implement a
workplace drug policy and/ordrug testing
program.
5)To identify the provisionsoutlined in the
workplace drug policies ofOregon manufacturing
companies.
6)To identify the proceduresand testing methods
utilized in the drug testingprograms
administered by Oregon manufacturingcompanies.
7)To determine how Oregonmanufacturing firms
evaluated the effectivenessof their drug
testing programs.6
8)To identify the drug abuserelated services
offered through Oregonmanufacturers' employee
assistance programs.
Hypotheses and Research Questions
The following null hypotheseswere tested as part of
the investigation of Oregonmanufacturing companies:
1)Ho: There will be no significantdifferences
between organizations with drugpolicies and
organizations without policiesbased on
industry classification.
2)Ho: There will be no significantdifferences
between companies with drug policiesand
companies without policiesbased on
organizational size.
3)Ho: There will be no significantdifferences
between organizations that conductdrug testing
and organizations that do nottest based on
industry classification.
4)Ho: There will be no significantdifferences
between organizations thatconduct drug testing
and organizations that donot test based on
organizational size.
In addition, the followingresearch questions were
considered:
1)What factors or issues supportedthe decision to
implement or not implementa written organiza-
tional drug policy?
2)What provisions characterizedthe workplace drug
policies implemented byOregon manufacturers?7
3)What factors or issuessupported the decisionto
implement or not implementan organizational
drug testing program?
4)Who would be eligiblefor taking a drug testand
under what circumstanceswould a test be
administered?
5)What methods andprocedures characterized the
drug testingprograms of Oregon manufacturers?
6)How have organizations withdrug testing pro-
grams evaluated the effectivenessof the
programs?
7)What drug related employeeassistance programs
or services are organizationsproviding
employees?
Significance of the Study
Substance abuse has beencharacterized as represent-
ing a national crisis.Various estimatesas to the econ-
omic cost of illicitdrug abuse place the annualloss near
$100 billion.Numerous national studies havedocumented
the use of anti-drugstrategies by the businesscommunity
to counter the threat ofdrug abuse in the workplace.
However, because thescope of the research has beenbroad,
the application of thefindings to specific geographical
areas or specific business sectorshas not been possible.
As with the nation, thestate of Oregon has experi-
enced economic losses attributableto workplace drug8
abuse.A 1985 study by the stateOffice of Alcohol and
Drug Abuse Program estimatedthe annual cost of drugabuse
at $500 million (Oregon BusinessCouncil, 1989).Informa-
tion regarding how theOregon business communityhas
responded to the problem ofdrug abuse has been limited.
To date, only one study ofthe anti-drug efforts ofOregon
companies has been completed.In a survey of 400 small
businesses (less than 100employees), Riley & Associates
(1989) reported only 20percent of the businesses hada
company drug policy, 20 percentprovided an employee
assistance program, andless than 10 percent administered
drug testing.Investigations of the anti-druginitiatives
of larger Oregon-basedcompanies have yet to beperformed.
Scope and Limitations
The focus of this investigationwas to assess how
Oregon manufacturing companieswere addressing the threat
of illicit drug abuse inthe workplace.Consequently, the
results of the studywere specific to the manufacturing
sector of Oregon industryand could not be generalizedto
all Oregon businesses.Also, because this researchwas
designed to collect informationfrom manufacturer's
employing at least 100people, the resultscan not be
generalized to all manufacturingcompanies in Oregon.
Any survey-based researchruns the risk of compiling
erroneous information due to samplingerrors or research9
design flaws.Because the sampling methodfor this inves-
tigation included collectinginformation from everycompa-
ny identified in the manufacturingsector population of
Oregon, the samplewas representative.However, given the
sensitive nature of theissues associated withworkplace
drug abuse and thecontroversy surroundingsome anti-drug
strategies, a self-selectionbias on the part of the
respondents may have occurred.In other words, com-
panies that respondedto the survey may representthose
which have taken stepstowards controlling illicitdrug
abuse in the workplace.
Finally, due to the necessityof narrowing thescope
of the research toa manageable study, the investigation
was limited to identifying theefforts by Oregon manufact-
urers in combating employee druguse.Consequently,
issues relating to alcoholand other drugs (i.e.,pres-
cription drugs, over-the-countermedications) were not
included in thesurvey instrument.Although abuse of
these substancescauses many of the same workplace prob-
lems as illicit druguse, their status is often left
unclear in company drug preventionefforts. In part, this
may be due to recent federalgovernment regulations man-
dating workplace drug preventionprograms for illegal
drugs (Deming, 1990).While the federal government's"War
on Drugs" has promoted the need tocombat illicit drug
use, none of the government's strategiesaddress abuse of
legal drugs, suchas alcohol.10
Definition of Terms
The following termswere defined for use in this
study.
Chain of Custody:Handling samples ina way that supports
legal testimony toprove that the sample integrity
and identification of thesample have not been
violated, as wellas the documentation describing
these procedures (Rosen,1987).
Drugs:Substances classified underthe schedule I or II
of the Controlled SubstancesAct, including opiates,
cocaine, marijuana,hallucinogens, and their
derivatives (Campbell& Graham, 1988).
Drug education/awarenessprograms:Educational programs
that can consist of seminars,films, meetings,
lectures, and/or written materialsdesigned to
acquaint employees withthe dangers of drugs.
Training to helpmanagers and supervisors identify
and deal with employee'sdrug use may also be
included (Myers, 1984).
Drug Policy:A written statement detailinga company's
policy with respect tothe use of drugs by its
employees.A policy may also outlinethe procedures
and criteria for drug testing,if applicable
(Thompson, 1990).
Drug Test:A test designed to detectthe presence of
metabolites of drugs in urineor blood specimens
(Potter & Orfali, 1990).11
Employee Assistance Programs:Company sponsored programs
available to employees toreceive help for a variety
of personal problems, includingdrug abuse.The
programs can be run internally bycompany personnel
or through an outsideagency that has been contract-
ed for services (Masi,1984).
False negative:An erroneous result ina drug test that
indicates the absenceof a drug that is actually
present (Crown & Rosse,1988).
False positive:An erroneous result ina drug test that
indicates thepresence of a drug that is actually
not present (Crown &Rosse, 1988).
Metabolite:A compound produced from chemicalchanges of
a drug in the body (Potter & Orfali,1990).12
CHAPTER II
LITERATURE REVIEW
Introduction
Drug abuse has been describedas a "disease" affect-
ing the social and economic fabricof American society
(Campbell & Graham, 1988).This discussion examines how
U.S. industry has responded to the problemof drug abuse.
Attention is first directed at theprevalence of drug abuse
and it's economic costs.This is followed by a review of
the workplace strategies companieshave developed to coun-
ter the threat of drug abuse.Finally, the discussion
considers these issuesas they pertain to Oregon.
Substance Abuse in the United States
Despite recent evidence that theuse of illicit
drugs is decreasing, the United States continuesto have
the highest rates of druguse among the world's industrial-
ized nations (Weiss & Millman, 1989).
Beginning in 1971, a series of nationalsurveys
sponsored by the National Instituteon Drug Abuse (NIDA)
was conducted to ascertain the prevalence of illicitdrug
use in the United States (Axel, 1990).Based on the 8,038
interviews conducted for the 1985 NationalHousehold Survey13
on Drug Abuse, the NIDA projected thatthere were 18 mil-
lion marijuana users and5.8 million cocaine users ("user"
being defined as using thedrug during the previous month)
(Voss, 1989).NIDA reported 19 percent of allAmericans
over 12 years of age had used illicitdrugs sometime during
the year prior to thesurvey.The highest usage rates were
found in two demographicgroups: males aged 18 to 25 and
males between 26 to 36years of age.In the 18- to 25-
year -old young adult population, 65percent had used illic-
it drugs, 45 percent withinthe last year (Walsh & Gust,
1986).
While the level of drugabuse has been characterized
as a national problem, alcohol continuesto be the most
widely used and abusedsubstance (Banta & Tennant, 1989;
Castro, 1986; Potter & Orfali,1990).According to the
National Instituteon Alcohol Abuse and Alcoholism,approx-
imately 12 million peoplehave an alcohol abuse problem
(Castro, 1986).Five percent of the adult populationare
considered alcohol dependent,as defined by the medical
diagnostic criteria (Banta& Tennant; 1989).
Substance Abuse in the Workplace
Within the drug abuse literature,the problem of
Substance abuse in theworkplace is usually described in
broad terms.General estimates suggested between10 and 23
percent of all U.S. workers usedillegal drugs on the job
(Backer, 1987).For alcohol, the estimate is that 1014
percent of the U.S. workforce abusedalcohol (Masi, 1984;
Potter & Orfali, 1990).Within this group, 25 percentwere
identified as "white collar"workers, while 30 percent were
considered to have "blue collar"jobs (Masi, 1984).
Research directed at the problem ofworkplace drug
abuse has provided estimations of theprevalence of drug
usage in the workforce.Cook (1989) analyzed the data from
a 1985 Gallup Organization survey (n= 3000)to determine
the extent of marijuana and cocaineuse among working
adults.Using the information obtainedfrom the 1,716
adults employed outside the home,Cook examined the rela-
tionship between occupation categories,demographic charac-
teristics, and two druguse measures: "current" use (de-
fined as reported marijuanaor cocaine use within the past
30 days), and "recent"use (defined as reported use in the
past year).The most significant indicator ofdrug use was
age, with 20 percent of the respondents inthe 18 to 34 age
group being identified as current marijuanausers and 30
percent being considered recentusers.
Based on its 1985 National HouseholdSurvey on Drug
Abuse, the National Instituteon Drug Abuse (NIDA) revealed
that approximately 30 percent ofemployed Americans between
the ages of 20 and 34 had usedan illicit drug at least
once during the previous year.Nineteen percent reported
use within the month preceding thesurvey (Voss, 1990).
When employment categorieswere considered, production15
operators and fabricators represented the occupational
groups with the highest incidence of drug use.
Data from the 1988 NIDA National HouseholdSurvey
indicated that 70 percent of the respondents reporting
current drug use were employed either full-time (55per-
cent) or part-time (15 percent) (NIDA, 1990).Two demo-
graphic groups were found to have the highestrates of drug
use.Twenty-four percent of males aged 18 to 25years, and
15 percent of males aged 26 to 34 yearswere identified as
current users (NIDA, 1990).
Smaller studies have also provided evidence of the
prevalence of workplace drug abuse.Walsh and Yohay (1987)
described a survey of 227 callers toa national cocaine
helpline.According to the survey results, 75 percent of
the respondents admitted using drugson the job, 64 percent
believed that drugs interfered with their workperformance,
and 18 percent reported stealing from their employersto
support their drug use.
The perceptions of workplace managers and supervi-
sors have attested to the extent drugs have affected the
business community.From 1971 through 1986, Schreier
(1987) polled management personnel froma sample of compa-
nies to track substance abuse issues.In comparing the
results from the four surveys, Schreier (1987) reported
that the number of respondents indicating their organi-
zation had to "deal directly with employee on-the-jobdrug
use" rose from 36 percent in 1971 to95percent in 1986.16
In assessing managers' perceptions regarding their organi-
zations' drug abuse problems, 98 percent of those polled in
the 1985 study felt the problem had either not changed or
had become worse during the past five years.
The Economic Costs of Drug Abuse
In 1985, a computer operator for a major airline who
had been smoking marijuana prior to his work shift failed
to load a tape into a computer reservation system.As a
result the system was out of service for eight hours,
costing the company approximately $19 million (Backer,
1987).The incident was characterized by the airline's
president as representing the most expensive jointever
smoked.
Few would disagree with the assertion that drug
abuse is costly both to the individual and society at
large.In the U.S. News & World Report article "How Drugs
Sap the Nation's Strength," Saroff and Hogue (1985) sug-
gested that the limited growth of U.S. manufacturing output
between 1967 and 1981, relative to other industrial coun-
tries, was related to drug abuse.Conceding that drug
abuse wasn't the only problem facing U.S. industry, the
authors asserted drugs have been "throwing sand in the
nation's industrial engine" (p. 55).
The most widely cited statistics relating to the
economic impact of drug abuse are derived from the Research
Triangle Institute's 1984 report to the Alcohol, Drug17
Abuse, and Mental Health Administration (as cited in Axel,
1990; Backer, 1987; Castro, 1986; Gordon, 1987; Williams,
1986).According to the RTI study, drug abuse cost the
U.S. economy an estimated $46.9 billion in 1980 (Harwood et
al., 1988).For the same year, the economic costs associ-
ated with alcohol abuse came to $50.6 billion.Harwood et
al. (1988) based their estimates on a number of factors,
including reduced productivity, lost employment, job-
related injuries and fatalities, and increased health
benefits utilization.Using the methodology of the origi-
nal RTI study, current estimates place the economic costs
of drug and alcohol abuse at over $120 billion a year
(Banta & Tennant, 1989; Feingold, 1989; Potter & Orfali,
1990).
Empirical evidence of the indirect costs associated
with drug abuse can be found in a number of retrospective
and prospective studies investigating the relationship
between drug use and various work-related variables.
Recent research, utilizing workplace drug test results as
indicators of drug use, had examined the impact of such
usage on performance and productivity measures, notably
absenteeism, accidents, job turnover, and health care costs
(Gust & Walsh, 1989).Acknowledging a positive drug test
result does not constitute proof of impaired job perfor-
mance or infer intoxication at the time of the test, Gust
and Walsh asserted that for research purposes, drug testing
data provides an "objective marker of recent use."18
Crouch et al. (1989) examined the drugprogram for
the Utah Power and Light Co. to assess the relationship
between drug use and job performance.The company incorpo-
rated drug testing as part of the pre-employment medical
physical in 1985 and instituted a "for cause" testing
policy for employees in 1986.Four groups were evaluated
in the study: a drug test positivegroup, a group of em-
ployees who had voluntarily entered intoa company drug
rehabilitation program, and two controlsgroups matched
according to demographic and geographic characteristics,
and job classification.The researchers reported drug
using employees had significantly higher absenteeismrates
than controls.Drug positive employees utilized sick leave
at a rate 35 percent higher relative to control employees
and unexcused absences at a rate 240 percent greater than
control employees.The drug positive group was also 5
times more likely to have been involved ina reportable
vehicle accident with a company vehicle for which the
driver was considered "at fault."
In one of the first large-scale prospective studies
reported in the literature, Normand and Salyards (1989)
described their findings from an ongoing U.S. PostalSer-
vice study.To assess the relationship between drug test-
ing results and two job performancemeasures (absenteeism
and job turnover), the authors were provided with the drug
testing results of 5,465 job applicants.Test results were
not disseminated to any Postal Service personnel to insure19
that any future personnel-related actionswere not influ-
enced by the testing results.Of the eventual 4,375 who
were hired, 8.4 percent (n= 354) had tested positive for
illicit drugs.Analysis of the data after one year sug-
gested a significant association between drug test results
and absenteeism and job turnover.Employees who tested
positive were found to be absent ata rate 43 percent
greater than new employees who tested negative.Involun-
tary job separation (i.e., Postal Service initiated employ-
ee termination) was 40 percent higher among the drug posi-
tive employees.
Corporate Drug Abuse Prevention Strategies
Evidence of the extent and cost of illicit drug
abuse in the workplace caused many companies to develop
various programs and anti-drug strategies.In recent years
the focus has been the importance of addressing the problem
of workplace drug abuse in a comprehensive fashion.Rather
than relying on a specific strategy, the emphasis has been
to develop comprehensive corporate drug preventionpro-
grams.In its National Drug Control Stategy, the federal
government described a comprehensive workplace drug preven-
tion program as including: 1) a written workplace drug
policy, 2) a drug testing program "where appropriate", and
3) an Employee Assistance Program (EAP) or similar services
that aid employees with drug abuse problems (Potter &
Orfali, 1990).In addition, employee drug education and20
supervisory training should be provided, eitheras part of
the EAP or as separateprograms (Potter & Orfali, 1990).
Each of the three workplace drug prevention strategies,
drug policies, drug testing, and drug abuse assistance
programs, will be considered in the following sections.
Workplace Drug Policy
In its general form, a formal, written workplace
drug policy should articulatea company's stand against the
use of illicit drugs, define the parameters ofa company's
drug prevention program, and outline theconsequences for
not abiding by the policy's provisions (Banta& Tennant,
1989; Thompson, 1990).The development of company drug
policies is a recent phenomenon thatgrew out of the recog-
nition that drug abuse representeda problem in the work-
place, and by the active promotion of such policiesby the
federal government (Banta & Tennant, 1989).
Drug-Free Workplace Act
The Drug-Free Workplace Act of 1988 requiredall
federal contractors and organizations receivingfederal
funding to implement a workplace drug abuse policy(Axel,
1990; Kiell, 1990; Thompson, 1990).Under the provisions
of the Act, companies were required to certify thatthey
would provide for a drug free workplace.Certification was
gained by developing a company drug policy which prohibited21
employees from taking part in the unlawfulmanufacture,
dispensation, distribution, possession,or use of a con-
trolled substance in the workplace (Kiell,1990; Thompson,
1990).
In addition, the federal legislation stipulatedthat
the workplace drug policy must specify theactions taken in
the event an employee violated policyprovisions.Further-
more, as a condition of employment, employees would be
required to abide by the drug policy.Finally, the Act
mandated the establishment ofan employee education program
to inform the workforce of the dangersof illegal drugs and
the availability of any assistanceprograms.Companies
that failed to meet the certificationrequirements of the
Act were subject to termination of federalcontracts and
exclusion from future contracts forup to five years
(Thompson, 1990).
While most private sector businesseswere not bound
by the requirements of the Drug FreeWorkplace Act, the
legislation did act as a catalyst for theproliferation of
company drug policies throughout U.S. industry.Companies
with federal contracts began toencourage subcontractors
and vendors to develop their own "drug-freeworkplace"
policies (Axel, 1990).In addition, adopting a policy pro-
claiming a company's opposition to illegaldrugs was per-
ceived to be good for "community relations"(Axel, 1990).22
Drug Policy Provisions
In its general form, a writtencompany drug policy
outlines provisions that addressa number of workplace and
workforce issues.In the first section of the policy,a
statement conveying the company'sconcern for the health
and safety of its employees is usuallypresented (Thompson,
1990).Recognition that drug abuse representsa problem
within the workplace should also be included.Finally, the
first part of a policy should describethe efforts taking
place within the company (Thompson, 1990).
Additional policy provisions should prohibitthe
"unlawful manufacture, distribution, dispensation,pres-
ence, or use of controlled substances in the workplace"
(Thompson, 1990, p. 67).Descriptions of the banned sub-
stances (e.g., alcohol, illegal drugs) and theparameters
of the ban (e.g., company property,company sponsored
activities away from the worksite)are usually outlined as
well.
For organizations with drug testingprograms, a
section describing the differentaspects of the program
should be included in the workplace drug policy(Thompson,
1990).The types of drug tests used (e.g., pre-employment,
employee "for cause") and the guidelines ofthe testing
process are usually specified in this section.
Finally, a company drug policy should outlinewhat
actions would be taken in the eventan employee violated
any of the policy's provisions (Thompson, 1990).23
Generally, disciplinary actions range from referringpolicy
offenders to the employee assistanceprogram, to termina-
tion (Banta & Tennant, 1989).
Drug Testing
Of the different drug prevention strategies utilized
today, drug testing has received the most attention.
Despite being controversial, the prevalenceof drug testing
has increased dramatically in recentyears.In 1984, only
3percent of the Fortune 500 companieswere identified as
using drug testing (Axel, 1990).By 1990, approximately 50
percent of the companies were reported to havedrug testing
programs (Axel, 1990).
Federal Government Advocacy
Drug testing was pioneered within the federalgov-
ernment by the military during the post-WorldWar II occu-
pation of Japan (Stone & Thompson, 1988).To deter possi-
ble drug use by military personnel stationedin Japan, the
military began conducting drug tests.Drug testing by the
military continued on a limited basis untilthe early
1980s.In 1982, the Department of Defense instituted
mandatory drug testing of all military personnelin all
services branches (Banta & Tennant, 1989).The change was
in response to the 1981 crash ofa jet on a nuclear air-
craft carrier, which killed fourteen peopleand caused $30024
million in damage (Decresce et al., 1989).The subsequent
investigation determined thatsome members of the jet's
crew had traces of marijuana in their systems (Banta &
Tennant, 1989).
Since instituting mandatory drug testing for all
personnel, the military has reported dramatic results.
The U.S. Navy found the percentage of personnel testing
positive for illegal drugs dropped from 47 percent in1981
to only 4 percent in 1986 (Bitter, 1990).By 1986, the
Department of Defense had discharged 16,500 members of the
armed forces and had provided rehabilitation for another
55,900 following positive test results (Banta & Tennant,
1989).
During the latter part of the 1980s, the federal
government began to issue regulations which expanded drug
testing beyond the military.In 1986, President Reagan
issued an executive order mandating the random drug testing
of federal personnel in sensitive positions (Axel, 1990).
Sensitive-position employees were definedas personnel with
access to classified security information, law enforcement
officers, and those in positions involving publicsafety
(Thompson, 1990).
Regulations issued in 1988 by two federal government
agencies extended government mandated drug testing intothe
private sector (Axel, 1990).First, the Department of
Transportation issued regulations requiring the transporta-
tion industry to administer drug tests to employees with25
jobs involving public safety (Bitter, 1990).Some four
million employees in the air transport, railroad,maritime,
and mass transit industries were affected by thenew rules
(Thompson, 1990).In addition, the Department of Defense
(DOD) issued regulations mandating companies withDOD
contracts to establish drug testingprograms (Kiell, 1990;
Thompson, 1990).Specifically, contractors were required
to conduct "reasonable cause" drug testing of allemployees
and random testing of employees in security sensitive
positions (Thompson, 1990).As a result of federal govern-
ment regulations, the prominence of drug testing inthe
private sector grew rapidly.
Types of Drua Testing
Drug testing programs are classified by two broad
categories: pre-employment testing and employee testing.
Employee drug testing includesa number of different types
of drug tests, notably universal testing, "forcause"
testing, and random testing (Thompson, 1990).
Pre-Employment Testing
Pre-employment drug tests are administered to job
applicants as part of the pre-hiringprocess (Cowan, 1987).
According to Cowan (1987), the objective of pre-employment
drug screening is to avoid hiring potential "problem"
individuals and to hire a drug free worker.The author
questions whether this objectivecan be fulfilled by drug26
testing.Because most drugs do not leave detectable traces
in the body after a week (exceptions beingmarijuana and
barbiturates), an individual can abstain fromdrug use for
a short time in order to pass a drug test.Despite this
limitation, pre-employment testing represents themost
common type of drug screening used by U.S. companies
(Thompson, 1990).
Mandatory, Universal Testing
Although it represents the least common form of drug
testing, across-the-board screening of allemployees does
occur (Thompson, 1990).This type of testing programcan
be found in public agencies with safety-sensitiveposi-
tions, notably police forces and fire departments(Thomp-
son, 1990).Within the private sector, universal drug
testing usually occurs as part ofa regularly scheduled
employee physical examination.In addition, Department of
Transportation regulations mandate that companies inthe
transportation industry must administer biennialdrug tests
to all employees whose positions involve publicsafety
(Thompson, 1990).
"For Cause" Testing
Employee drug tests triggered by specific conditions
or events constitute the "for cause" type of testing
(Cowan, 1987; Thompson, 1990).This screening involves an
employee submitting to a drug test afteran event, such as
a worksite accident, or when a "reasonable suspicion"27
exists indicating impairmentdue to possible drug use
(Thompson, 1990).
Suspicion-triggered testing usually involvessuper-
visors observing and documentingjob-related indicators
(e.g., dramatic changes in workperformance, excessive
absenteeism and tardiness),or physical symptoms (e.g.,
dilated pupils, slurred speech,diminished motor coordina-
tion) which could be attributedto illicit drug use (Grey &
Stein, 1988; Kiell, 1990; Thompson,1990).
An important component ofa "for cause" drug testing
program is the proper training of supervisory personnelin
recognizing possible drug abuse indicators(Thompson,
1990).In its regulations mandating "for cause"testing in
the transportation industry, the federalgovernment re-
quires companies to providesupervisor training as part of
the testing program (Thompson, 1990).
In addition to the reasonable suspicioncriteria,
"for cause" testing is usuallymandated after any workplace
accident (Thompson, 1990).Thompson (1990) suggests the
objective of post-accident drug testingis to ascertain
whether drug use wasa possible contributing factor for
reasons of liability and possible litigation.
Randym Testing
Random testing involves mandatory,unannounced drug
tests administered to employees without priornotice
(Thompson, 1990).Proponents argue that random testing
provides the best deterrent toemployee drug use because28
employees cannot predict when they will be tested
(Thompson, 1990).Critics maintain random testing is based
on a "guilty until proven innocent" premise thatcan have a
negative impact on employee morale (Axel,1990).Although
it is considered the most controversialform of testing,
rulings by different judicial courts haveupheld the legal-
ity of random testing for positions involving publicsafety
and security (Carrell & Heavrin, 1990).
Drug Testing Methods
Although there are a variety of drug testingtech-
niques, the most commonare urinalysis and blood tests
(Potter & Orfali, 1990).
Urinalysis
Urinalysis refers to the chemical analysisof urine
(Potter & Orfali, 1990).Stone & Thompson (1989) maintain
the prevalence of urinalysis has made the drugdetection
method synonymous with drug testing.Testing urine is the
most common detection method because of theease of col-
lecting a valid sample, and because the chemical analysis
can be done quickly (Potter & Orfali, 1990).The major
disadvantage of urinalysis is that chemical tracesof drugs
can remain in the urine long after the drugs had been used
(Crowe & Rosse, 1988).Consequently, urinalysis may not
indicate whether an individualwas under the influence of a
drug at the time the urine samplewas collected.29
There are two major methods of urinalysiscommonly
used today: enzyme immunoassay/radioimmunoassay, and gas
chromatography/ mass spectrometry (Potter& Orfali, 1990).
Immunoassay procedures represent the mostcommon
form of urinalysis screening (Rosen,1987).Because these
procedures are less expensive ($15 to $25per test) than
other urinalysis methods (e.g,gas chromatography, mass
spectroscopy), and can be processed quickly,immunoassay
methods are generally used to initiallyscreen urine sam-
ples for traces of targeted drugs(Potter & Orfali, 1990).
The disadvantage of immunoassay urinalysisis the limited
range of drugs it can identify.As a result, substances
such as over-the-counter medicationsand even some foods
(e.g., poppy seeds, herbal teas)can produce false-positive
results (O'Keefe, 1987; Potter & Orfali,1990).
The enzyme immunoassay technique and theradioimmu-
noassay procedure utilize the chemical interactionof
target drugs and drug antibodiesto measure the presence of
drugs (Kupfer, 1988).The differences between theseproce-
dures are in how the chemical changesare measured: radio-
immunoassay utilizes radioactive isotopes,while enzyme
immunoassay measures drugenzymes (Kupfer, 1988; Potter &
Orfali, 1990).Both techniques have a 5 to 10 percent
error rate associated with them (Kupfer, 1988).
The most sensitive and accurate urinalysistest is
the gas chromatography/ mass spectroscopytesting method
(Potter & Orfali, 1990; Rosen, 1987).Positive30
identification of thepresence of a targeted drug is made
by breaking down the drug into its constituentmolecules
(Kupfer, 1988).Although highly accurate (99 to 100per-
cent), the procedures are expensive ($60 to $70per test).
Consequently, these urinalysis techniquesare generally
used to confirm the presence ofa drug found in a sample
following as initial screening (Potter & Orfali,1990).
Blood Testing
Blood samples are generally not used in routine
screening of individuals for illicit drugs fora number of
reasons (Decresce et al., 1989).First, drawing blood is
an invasive procedure requiring specially trainedperson-
nel.More importantly, bloods tests can only indicate
very recent drug use on account detectable levels of drugs
or their metabolites disipate quickly in the blood.For
example, less than 25 percent of the peak levelof cocaine
remains in the blood five hours after ingestionof the drug
(Decresce et al., 1989).By contrast, traceable levels of
cocaine can be found in urine for severaldays after inges-
tion.For these reasons, blood testsare rarely used,
except as a confirmation test followingan initial positive
urine screen (Potter & Orfali, 1990).
Drug Testing Issues
The controversy surrounding theuse of drug testing
generally involves two issues, theaccuracy and the31
legality of drug tests.
Legal Implications
According to Crown & Rosse (1988), themost debated
assumption regarding drug testing is its legality.Legal
challenges and subsequent court rulings have definedthe
legal parameters of the different types oftesting.Oppo-
sition to drug testing has centeredon several basic legal
arguments, namely, testing representsan invasion of priva-
cy, and constitutes an unreasonable search and seizure in
violation of the Fourth Amendment(Crown & Rosse, 1988).
Drug testing is often accused of beingan invasion
of an individual's right to privacy.Yet, as Crown & Rosse
(1988) observed, there is no constitutional rightto priva-
cy."Privacy rights" such as the freedom ofspeech and the
right to protection against self-incriminationhave been
combined to form the legal concept knownas the "right to
privacy" (Crown & Rosse, 1988).In addition, a number of
states have privacy rights laws stemming from theirstate
constitutions.
Despite these arguments, legal challengesto drug
testing based on the right to privacy havenot been upheld.
In the few exceptions where testingwas found to be viola-
tion of a state's privacy right, the issuewas the breadth
of the testing program, and not the legalityof drug test-
ing itself (Crown & Rosse, 1988).
Critics of drug testingargue, based on the Fourth
Amendment, that the collection of body fluids represented32
an unreasonable search and seizure (Crown & Rosse, 1988).
Although several lower court decisions haveruled specific
"reasonable cause" and random drug testingprograms to be
unconstitutional by virtue of the FourthAmendment, the
U.S. Supreme Court has upheld theprograms (Crown & Rosse,
1988; Carrell & Heavrin, 1990).In addition, in a series
of recent decisions, the U.S. Supreme Courtupheld drug
testing of federal employees who handle securitysensitive
material (National Treasury Employees Unionvs. Von Raab),
pre-employment testing within the transportation industry
(New York City Transit Authorityvs. Beager), and post-
accident "for cause" drug testing (Skinnervs. Railroad
Labor Executives Association) (Carrell & Heavrin,1990).
Carrell & Heavrin (1990) observed that fornow, drug test-
ing programs which adhere to the guidelinesand testing
criteria provided in federal governmentregulations were
permissible by law.Beyond these parameters, the legality
of drug testing will continue to be defined inthe courts.
Drug Testing Accuracy
Another common argument against theuse of drug
tests is in regards to its accuracy.Specifically, do drug
tests accurately measure drug use?
Validity of Measurement
In the context of drug testing, validity of
measurement pertains to whether the test accurately indi-
cates drug use (Crowe & Rosse, 1988).Crowe & Rosse (1988)
suggested that the reliability and measurement validity of33
drug tests depend on the type of test used andthe profi-
ciency of the laboratory conducting the chemicalanalysis.
Among the different type of testing methods, the levels of
accuracy range from 90 to over 99 percent (Rosen, 1987;
Kupfer, 1988).Of greater concern is the accuracy
and reliability of the laboratories responsible forthe
chemical analysis.
According to Crowe & Rosse (1988), drug testaccura-
cy is generally defined in terms of the number of true
positives (detection of substances) and true negatives
(correct reporting of no substances) relative to false
positives (sample incorrectly identifiedas containing
tested-for substances) and false negatives (failure to
identify sample containing tested-for substances).The
accuracy rate for a screening laboratory is often deter-
mined by sending test samples with known concentrationsof
targeted substances to the facility for analysis (Crowe&
Rosse, 1988).Studies indicate the accuracy of some labo-
ratories has been disturbinglypoor.
Investigations of laboratories employing profession-
al staffs and adhering to stringent quality controlproce-
dures have reported accuracy ratings of 99 percent (Crowe&
Rosse, 1988).Other studies have found accuracy rates for
some commercial laboratories to be well below this level.
A series of Center for Disease Control (CDC) studies of 13
laboratories over a ten year period found the rate of false
positives ranged from zero to 37 percent, while false34
negatives ranged from 11 to 94 percent (Crowe & Rosse,
1988; O'Keffe, 1987).Even when laboratories were notified
in advanced that test samples were sent, theCDC revealed
drug-detection error rates up to 10 percent (O'Keefe,
1987).
Validity of Prediction
Validity of prediction refers to the ability of
drug tests to predict how well an individual will perform
on the job (Crowe & Rosse, 1988).Crowe & Rosse (1988)
observed that the assumption underlying theuse of drug
tests was that the presence of drug metabolites (chemical
byproducts of the chemical breakdown of substances in the
body) indicated the use of drugs at a time when it would
have interfered with job performance.More precisely, the
authors maintained drug tests do not necessarily determine
impairment because some drug metabolites could be detected
long after the drugs were used (e.g., barbiturate traces
are detectable in urine up to 37 days; marijuana metabo-
lites can be identified 5 to 30 days after use). O'Keefe
(1987) asserted that the job relatedness of drug tests,
when accurate, can not be assured for all situations.
Employee Assistance Programs
Employee assistance programs (EAPs) are designed to
"prevent problems that interfere with an employee's ability
to perform his or her job and to rehabilitate those employ-
ees who are experiencing problems that affect the35
employee's performance on the job" (Crino & Leap,1989, p.
556).The popularity of EAPscomes from the recognition
that the personal problems of employeescan adversely
affect their job performance (Masi, 1984).
History of EAP Development
In 1917, Macy's Department Store in New York opened
an office specifically devoted to helping employees deal
with "personal" problems (Campbell & Grahams,1988).Em-
ployee assistance efforts remained relegated toa few large
companies until the early 1940s and the rise of Alcoholics
Anonymous (AA) (Masi, 1984).As AA became more prominent,
it began encouraging employers to rehireemployees formerly
terminated for problems relating to their alcoholism (Masi,
1984).The significant improvement in work productivity of
the returned employees prompted several large organiza-
tions, notably the DuPont Company, Eastman Kodak,and
Kempler Insurance, to institute formal occupational alco-
holism programs (Masi, 1984).Generally, these early
programs were staffed by recovered alcoholics and were
intended to identify and provide assistance for thealco-
holic employee.This marked what Myers (1984) described as
the initial development phase of the EAP concept.
Despite the success of the early occupational alco-
holism programs, the end of the 1940s foundmany programs
no longer functioning.Masi (1984) attributed the failure
of the early employee assistance efforts to the social36
stigma of alcoholism asa moral weakness, and the general
denial that alcoholism representeda problem to the busi-
ness community.
The second phase of employee assistanceprogram
development began in the early 1960s followingthe emer-
gence of the disease model of alcoholism (Myers, 1984).
Recognition of alcoholismas a disease facilitated a reori-
entation in the treatment of alcoholism, andchanged the
business community's attitude towards employeeswith alco-
hol abuse problems.Additional impetus to implementing
assistance programs came from federalgovernment legisla-
tion.Adopted in 1970, and amended twoyears later, the
Hughes Act mandated the establishment of drug andalcohol
programs in all federal agencies, and instituted thegover-
nment's role in advocating public and privatesector drug
prevention efforts in the workplace (Masi,1984).
During the 1970s, numerous companies beganto broad-
en the focus of their assistance programs to provideser-
vices for a variety of personal problemsthat could inter-
fere with job performance (Masi,1984; Thompson, 1990).
Masi (1984) argued that this changecame about with the
realization that recovering alcoholic employeesoften
experienced other problems (e.g., legal, marital)requiring
assistance.In addition, personal problems were not exclu-
sive to recovering alcoholics;any employee with personal
difficulties could benefit from EAP services.The broad-
based EAP model prevalent todaygrew out of the recognition37
by the business community that providing assistance for
troubled employees was good for a company (Masi, 1984).
As the value of the employee assistance concept
gained greater recognition, the number of employee assis-
tance programs increased dramatically.In 1972, only 25
percent of Fortune 500 companies reported providing EAP
services for their workforces (Thompson, 1990).By 1979,
the prevalence of EAPs among the top 500 companies
increased to over 60 percent (Thompson, 1990).According
to the literature, 1990 estimates placed the number of EAPs
in this country at 17,000 (Kinnan, 1990; Thompson, 1990).
Employee Assistance Program Models
Employee assistance programs are generally classi-
fied as one of two basic models: internal and external EAPs
(Duda, 1990; Masi, 1984; Myers, 1984).Internal EAPs are
in-house programs staffed by personnel employed by the
organization they serve (Masi, 1984).By contrast, exter-
nal EAPs are operated by personnel who are employed by an
agency contracted to provide EAP services, and are usually
located away from the company worksite (Masi, 1984).
Internal EAP Motel
By definition, internal EAPs (also referred to as
employer EAPs) involve on-site programming staffed by
individuals employed by the company (Masi, 1984; Thompson,
1990). The breadth of assistance provided by internal EAPs38
ranges from a part-time counselor conducting employee
education and assessments, to large staffed programs offer-
ing extensive on-site services.The more common form of
the internal EAP utilizes a small staff of counselors who
conduct employee interviews, and provide assessments (Masi,
1984).Should additional attention or treatment be deemed
necessary, an EAP counselor refers the employee to the
appropriate public or private community resources.
An often cited advantage to an internal EAP is the
accessibility of on-site services to employees (Masi, 1984;
Thompson, 1990).Some authors consider this a disadvantage
arguing that employees will fear beingseen entering or
leaving the EAP office(s) by people they work with, includ-
ing their supervisor (Myers, 1984).Myers (1984) suggests
this concern can be alleviated by offering counseling
services off-site, while Thompson (1990) maintains educat-
ing the workforce as to the EAP's function will minimize
this problem.
Another advantage in-house assistance programs
provide is allowing the EAP counselors to function inan
advocacy role for employee clients (Myers, 1984).As
employees with the same company, counselors have an under-
standing of the unique "corporate culture," andare better
able to establish lines of communication with supervisors
and other personnel (Thompson, 1990).
Finally, the internal control inherent with an
in-house EAP structure allows for flexibility in the39
programming and procedures not found with theexternal
model (Masi, 1984; Thompson, 1990).Any facet of a program
can be modified to meet the unique needs foran entire
organization or just one work site.Similarly, changes in
EAP procedures and policies can be mademore readily than
with an external EAP structure.
The principle disadvantages of the internal EAP
model are the potential risks to confidentialityand ano-
nymity (Masi, 1984).The fear of disclosure to one's peers
or supervisors can dissuade problem employees from seeking
assistance.
External EAP Model
As previously stated, external employee assistance
programs are staffed and personnel employed by an organiza-
tion contracted to provide EAP services (Masi,1984; Myers,
1984; Thompson, 1990).There are two types of external EAP
models, the consortium and the contractor (Myers, 1984).
Consortiums
Consortiums are non-profit agencies receiving
funds from various sources (e.g., county, state,and/or
federal governments, companies) to provide assistance
services to public and private organizations (Myers, 1984).
Like other EAP structures, considerable differencescan be
found among consortiums regarding both the number and
quality of functions performed.Regardless of the size of
the consortium, it offers several advantages in providing
EAP services.One benefit is the off-site location of the40
consortium's facilities (Myers, 1984).Masi (1984) notes
that employees often perceivean EAP located away from the
work-site as providing greater anonymity, confidentiality,
and privacy.Another advantage of the consortium structure
is that it provides almostany employer the opportunity to
of-fer some degree of employee assistance (Myers,1984;
Thompson, 1990).Referring to this economy of scale fac-
tor, Thompson (1990) asserts smaller companiesare able to
offer assistance services to employees because thecost is
shared by other employers.Myers (1984) notes this is
important since almost 80 percent of all privatesector
employees are employed by companies with fewer than100
workers.
The fundamental disadvantage of the consortium
structure is that the EAP counselors and staffmay lack a
thorough understanding of a client'scompany (Myers, 1984).
Consequently, the effectiveness of a counselor in assisting
an employee can be reduced.In addition, a company may be
less able to structure the EAP services to conform to its
particular needs (Thompson, 1990).By contracting servic-
es, a company gives up a measure of control of the services
and is limited to receiving only the services providedby
the EAP organization.
Contractors
The for-profit private contractor represents the
other type of external employee assistanceprogram (Myers,
1984; Thompson, 1990).Generally, the organizations41
represented by this model are of two types: 1)an agency
which provides specialized EAP services forone or two
problems, such as alcohol or drug abuse,or 2) a contractor
affiliated with a service provider, suchas a residential
care facility (Myers, 1984).With these providers, the
employer will usually have a staff member of the in-house
program facilitate the communication and proceduralconnec-
tion between the company and thecontractor (Myers, 1984).
Employees can contact the EAP contractor directlyor
through their supervisor or thecompany coordinator (Myers,
1984).
One advantage of contractor provided EAP services
includes off-site facilities and the resultantemployee
perceptions of greater confidentiality (Masi, 1984).Also,
the level of expertise among the EAP provider staff is
usually better than that of other EAP models (Myers,1984).
The principle disadvantage of this type of EAP model
is the cost (Myers, 1984).Contractors are generally more
expensive for comparable client services than consortiums.
In addition, some assistance programs affiliated witha
service provider have been criticizedas acting as a con-
duit for business to the affiliate (Myers, 1984).Myers
(1984) notes some residual treatment providers that
developed and marketed EAPs have been accused of funneling
referrals to their own service facilities.To avoid this
occurrence, it is important to investigate providers prior42
to contracting for services and to periodically evaluate
the results of the services (Myers, 1984).
Employee Assistance Programs Services
Services provided by Employee Assistance Programs
range from counseling, assessment, and referral activities
to workforce training and educationprograms (Thompson,
1990).The first group of functions are often classified
as employee or client services (Myers, 1984).
Client Services
"Client services" describes the activities, provided
by the EAP staff, designed to assist the employee.These
include problem assessment, service coordination,and case
management (Crino & Leap, 1989; Myers, 1984; Thompson,
1990).
One of the primary functions of an EAP is to help
identify those employees whose personal problemsare
detrimental to their job performance (Thompson, 1990).
Identification is accomplished through voluntary referral,
supervisory identificationor referral, and peer referral
(Thompson, 1990).
The information assessment and diagnosis services
usually involve an EAP counselor determining the nature of
an employee's problem (Myers, 1984).Masi (1984) asserts
this entails more than just listening toan employee, given
the apparent problem presented by the individualmay not be43
the real source of difficulty.Only then can the employee
be directed to the bestsource of assistance.
Once the nature of an employee's problem has been
identified, the EAP counselor developsan assistance plan
outlining the delivery of needed services andmakes a
referral to the appropriate service providers (Myers,1984;
Thompson, 1990).Service delivery may be rendered by the
EAP staff or with a contracted provider outsidethe compa-
ny.The type of assistance canrange from providing bud-
geting information foran individual experiencing personal
financial difficulties to referringan employee who has a
substance abuse problem toan in-patient treatment program
(Myers, 1984).
For employees completing some type of rehabilitation
program requiring them to be absent from work, the EAP
counselor can assist in the return of the individualto
their job (Myers, 1984).Sometimes an aftercare or follow
up program is needed for a returning employee who needs
continued assistance.Thompson (1990) asserts this
approach is especially critical in order to helpemployees
receiving substance abuse treatment maintain their
recovery.
Employee Education
Another component of an effective employee assis-
tance program is employee education (Masi, 1984; Myers,
1984; Thompson, 1990).The educational programs provided
by the EAP should be designed to accomplishseveral goals44
(Masi, 1984; Thompson, 1990).The first goal is to make
employees aware of the availability of the EAP.To accom-
plish this objective, the employer should develop and
disseminate information about the services available and
the procedures an employee can use to make contact with the
services (Thompson, 1990).
Another aim of the EAP should be to facilitate the
dissemination of information regarding issues andconcerns
that can affect employees and their abilitiesor job per-
formances (Masi, 1984).These problem areas can include
health, drug, family, marital, financial, legal, andemo-
tional difficulties (Thompson, 1990).
Finally, an assistance program should strive to
remove any existing social stigma that may discourage the
use of the EAP (Thompson, 1990).Thompson (1990) suggests
that employees will not use EAP services if they view the
services as a public admission that there is something
wrong with them.To counter this perception, an education-
al effort must stress both the confidential nature of the
program, and its purpose of assisting individuals experi-
encing problems with which they are unable tocope
(Thompson, 1990).
Supervisor Training
According to Thompson (1990), an employee assistance
program can not be successful without supervisors who are
well informed about the program and understanding of their
function as it relates to the program.Masi (1984) argues45
that the primary role of the supervisor is to determine
when an employee has a problem, as indicated by job perfor-
mance, and to motivate the individual to acknowledge the
problem and seek assistance through the EAP.
In order for supervisors to complete their function
of facilitating EAP referrals, they must know how torecog-
nize the relationship between job performance deterioration
and possible personal problems (Masi, 1984).Supervisor
training must also review both the policies of the assis-
tance program and the proper referral procedures to theEAP
(Thompson, 1990).
Responding to Drug Abuse in Oregon
Although the extent of illegal drug use in Oregon is
not known, information is available which illustratessome
of the problems attributed to drug abuse.Similarly,
information regarding how Oregon businesses have responded
to workplace drug abuse is limited.
Drug Abuse in Oregon
In its Drug Impact Index, the Regional Drug Initia-
tive (1991) provides a summary of the drug-related data
compiled by different organizations in Oregon.Taken
together, the information offers a sense of the impact of
illicit drug use in the state.Based on information pro-
vided by the State Medical Examiner's Office, the Regional46
Drug Initiative (RDI) reported 82 drug overdose deaths in
1990.This represents an 8 percent increase from the
number of deaths (n= 76) recorded in 1989.
As reported by the Regional Drug Initiative (1991),
the State's law enforcement agencies revealed 9,195adults
were arrested in 1990 for drug offenses.This represented
a slight decrease from the 10,646 arrests reported in 1988.
In terms of juvenile arrests, 631 young offenderswere
arrested for drug offenses in 1990.
Finally, the Regional Drug Initiative (1991)summary
presented some information pertinent to this investigation.
Oregon Medical Laboratories (OML) of Eugene reported 12
percent of all pre-employment drug screenings analyzed
(n= 24,000) tested positive for illicit drugs.
Oregon Businesses' Responses to Workplace Drug Abuse
A review of the literature indicates that research
of the Oregon business community's response to workplace
drug abuse has been limited, with only one study completed
to date.Riley Research & Associates (1989),a Portland-
based commercial research firm, conducteda survey of 420
small (less than 100 employees) Oregon businesses for the
Oregon Office of Alcohol and Drug Abuse and the Oregon
Business Council.The results suggested that fewsmall
companies have a workplace drug preventionprogram.
When compared to the federal government's outline
for a comprehensive drug prevention program, most small47
companies in Oregon have not implementedany of the strate-
gies advocated by the government.Only 20 percent of the
businesses reported having a "written drug-freeworkplace"
policy for their employees (Riley Research & Associates,
1989).The prevalence of drug testing waseven less: only
6 percent of the respondent companies administeredany drug
screening tests.Finally, 25 percent of the small busi-
nesses were found to have no employee assistance programs
to aid an employee with a drug abuse problem.
Additional anecdotal evidence of the Oregon business
community's response to the workplace drug abuseproblem
was also found in the literature.According to the Oregon
Business Council (1989), a number of Oregon companieshave
implemented drug testingprograms with encouraging results.
The Bohemia company implementeda workplace drug abuse
policy that included pre-employment drug testing duringthe
summer of 1985 (Oregon Business Council, 1989).Within a
few years of its enactment, the company'sWorker's Compen-
sation costs fell from $1.9 million in 1984 to $786,000in
1988.
In another example, the Business Council described
the Hoffman Construction company'sresponse to an annual
$500,000 increase in its liability insurance.In an effort
to control its losses, the company developeda new safety
program and implemented an employee drug testing program.
During 1987, within one year of implementing theprograms,
Hoffman's lost-time accidents decreased to only two.By48
contrast, the company recorded 33 accidents in 1985.In
terms of Worker's Compensation losses, Hoffman's costs
dropped from $986,000 in 1984 to $118,000 in 1987 (Oregon
Business Council, 1989).
Further details regarding both of these companies
and their respective drug preventionprograms were not
provided in the Oregon Business Council's report.The
Council did suggest that the improvements experiencedby
both companies were the direct result of the implementation
of a drug testing program.49
CHAPTER III
RESEARCH DESIGN AND METHODOLOGY
This chapter on research design and methodologyde-
scribes the procedures followed in the selectionof the
sample of Oregon manufacturing organizations, collection
of the data, and data analysis.
Sample
A sample population of 350 Oregon manufacturing
companies with 100 or more employeeswas utilized for this
study.Organizations with at least 100 employeeswere
selected for this investigation because informationper-
taining to smaller businesses' anti-drug effortswas avai-
lable from a recent survey of 420 firms with 99or fewer
employees (Riley Research & Associates, 1991).
The sample of Oregon manufacturers used in this in-
vestigation was identified from the Directory ofOregon
Manufacturers, 1989-1990.Published biennially by the
Oregon Economic Development Department, this directory
categorized manufacturing companies by the productsthey
produce and/or services provided in accordance with the
U.S. Office of Management and Budget's Standard Industrial
Classification (SIC) Code.Companies were listed alpha-
betically under the SIC number that corresponds with their50
primary product.Each listing included the organization's
address and phone number,one or more company executives
(CEO and/or "contact person"), numberof employees, annual
sales level, and whether the organizationengaged in ex-
port or import activities.Additional directory sections
cross-referenced the companies by alphabeticaland geo-
graphical (county and city) listings.
The first step in compiling thesurvey sample was to
identify the companies listing 100or more employees.
This process produced a listingof 379 companies.Because
the directory categorizes businesses byboth products and
geographical locations, the initial listwas reviewed for
duplicate listings of companies.Businesses with more
than one geographic location (e.g., BoiseCascade
Corporation: Portland, Salem, Medford)or product category
(e.g., Hewlett-Packard: calculating machines,medical
equipment) were counted asone organization.The resul-
tant 350 organizations were usedas the survey sample.
For the purpose of statistical analysis,respondent
companies were categorized by industryand size.Industry
classification was obtained from the Directoryof Oregon
Manufacturers, 1989-1990 in accordance withthe U.S. Of-
fice of Management and Budget's industrialclassification
system.Company size was defined by the number ofemploy-
ees and was provided by the survey respondents.
To insure the confidentiality of the data,a three
digit numerical code was assigned toeach survey sample51
company.This code was included on thesurvey question-
naire, and was used as the identificationnumber in the
survey data computer file.In addition, the cover letter
accompanying the mailed survey instrument containedstate-
ments assuring the respondents thatany information pro-
vided would be kept confidential andthat the results of
the survey would not identify anycompany specifically.
Survey Instrument
The instrument developed for this study, the
Organizational Response to Employee SubstanceAbuse Survey
(Appendix), contained nineteen questions andwas divided
into four parts.The first section presented questions
pertaining to issues associated with companies havinga
formal written drug policy.Section two addressed the
prevalence of programs and services available to assist
employees with drug problems.The third section provided
questions regarding the presence of drug testingprograms
and policies, while the last section requested demographic
data specific to each respondent company (e.g., typeand
nature of business, number of employees).
Because a questionnaire appropriate for thepurpose
of this investigation was not available,a survey instru-
ment was developed.The instrument design was based on
the literature review conducted by the researcher, and
four published national survey instruments (Axel, 1990;
Masters et al. 1988; Schreier, 1987; U.S. Department of52
Labor, 1989).Design assistance was also received from
the Survey Research Center at Oregon State University.
Pam Bodenroeder, research analyst with the ResearchCen-
ter, provided assistance in developing the organization
and presentation format of the survey text.
In addition to the aforementioned assistance received
during the questionnaire developmentprocess, a number of
steps were taken to insure the validity of the instrument.
First, the researcher consulted with Larry Stone,staff
researcher with the Regional Drug Initiative in Portland,
Oregon, to provide a critique of the questionnaire.His
evaluation and suggestions regarding how to elicitthe
desired information from Oregon manufacturerswere incor-
porated into the survey questions.The next step involved
field-testing the survey instrument with 12 companies
located in Corvallis, Oregon.Following the pretest,
revisions in the instrument were made, specifically inthe
wording and the sequence of some of the questions.Data
collected from the field-test were not included in the
final data compiled from the actualsurvey.
Data Collection
Quantitative information was obtained froma sample
of Oregon manufacturing organizations usinga survey in-
strument developed for this study.A packet containing
the survey instrument, a cover letter, and a business
return envelope was addressed to the company executive53
listed in the directory for each organizationcomprising
the sample.The Oregon State University MailingCenter
was contracted to facilitate the survey mailing and return
of completed survey instruments.Ten days after the ini-
tial mailing, printed "follow-up" cardswere sent to all
organizations that had not returneda completed question-
naire.Twenty days after the initial mailing,a second
"follow-up" card was sent to the remaining organizations
who had not returned a completedsurvey instrument.
Data Analysis
All quantitative data compiled for the studywere
derived from the respondent information providedon the
questionnaire.Prior to analysis, information from the
questionnaires was numerically coded for computerized
entry.Data analysis was completed using the statistical
software SPSS/PC+ V3.0 computer program for IBMpersonal
computers.
Data collected from completed questionnaireswere
nominal.Analysis techniques used to describe and
contrast the data included frequency distribution,cross
tabulation, and the chi-square statistic.An alpha level
of .05 was the basis for determining significance.54
CHAPTER IV
RESULTS
This research examined the strategiesOregon manu-
facturing organizations have adoptedto counter the use of
illicit drugs by their workforces.In this chapter the
study sample of Oregon manufacturersis first described.
This is followed by presentationof the results obtained
from the statistical analysis of theinformation pertaining
to the research questions and thehypotheses.
Characteristics of the Study Sample
Respondents
The primary respondents in thisinvestigation were
Oregon manufacturing companies with 100or more employees.
Of the 350 manufacturers comprisingthe survey sample, 152
returned a completed survey questionnaire,representing a
43 percent response rate.Organizational representatives
completing the survey instruments providedinformation
regarding company sponsoredprograms and policies designed
to counter the problem of workplacedrug abuse.Additional
information relating to companies' industriesand workforce
levels were also provided.Fifty-two respondents (53per-
cent) identified their position withintheir organization55
as involving personnel or human resource management.The
remaining respondent positions (n=97) were identified as
being in the areas of safety, generalmanagement (e.g.,
Vice President, Chief Financial Officer),and health and
benefits.Two respondents identified themselvesas being
the "owner" while another characterizedhis or her position
as the "boss."
Industries and Company Size
For this investigation, respondentmanufacturers
were categorized by industry classificationand size. In
terms of industry, 110 of the manufacturingcompanies
surveyed were affiliated withone of four industrial clas-
sifications: lumber and wood products(36.7 percent), food
products (14.0 percent), metal products(12.7 percent), or
electronics manufacturing (10.0 percent).The remaining
organizations were involved inone of ten different indus-
tries.Industry classifications identified bytwo or more
respondents included paper products, chemicalproducts,
machinery, transportation equipment,and apparel products.
Table 4.1 illustrates the representationof these indus-
trial classificationsas they pertained to the companies
surveyed.
In addition, four respondents identified their
companies as being affiliated with thefollowing indus-
tries: plastics manufacturing, glassproducts, medical
media product, and textile products.56
Table 4.1 Industrial Classificationsfor the
152 Manufacturing Companies Surveyed
Industries N (%)
Wood products 55 (36.2)
Food products 21 (14.0)
Metal products 19 (12.7)
Electronics 15 (10.0)
Paper products 9 (6.0)
Chemical products 6 (4.0)
Machinery 6 (4.0)
Transportation 5 (3.3)
Apparel products 2 (1.3)
In terms of the companies'size as defined by the
number of employees, the mostcommon workforce level (43.7
percent, n= 66) was between100 to 249 employees.Twenty-
one percent (n= 32) of the companiesreported having
between 250 and 499 employees, while21 percent (n= 32)
indicated having 500or more employees.
Twenty respondent companies, representing13 percent
of the total respondentgroup, reported their workforce
level as less than 100 employees.Although organizations
selected for this investigationwere identified in the
Directory of Oregon Manufqgturers.1989-1990 as having 100
or more employees, several factors couldaccount for the
discrepancy in the reportedworkforce level.First, sea-
sonal fluctuations in the supplyand demand of materials in
the lumber and food productsindustries often result in
variable employee levels.A review of the companies list-
ing less than 99 employeesfound over half to be lumber and
wood product manufacturers (54percent), and 23 percent to
be food product manufacturers.In addition, workforce57
levels for some firmsmay have decreased as aconsequence
of the recent recessionaldownturn in the nationaleconomy.
Study Results
To facilitate the review ofthe findings of this
investigation, the discussion isstructured to address the
following aspects of the study:
1. The four study hypothesespertaining to whether
manufacturing companies utilizeddrug policies or drug
testing based on industryclassification andcompany size.
2. The research questions pertainingto the develop-
ment and use of workplace drugpolicies by Oregon manufac-
turing companies.
3. The research questions pertainingto the use of
drug testing by manufacturingcompanies.
4. The research question pertainingto how Oregon
manufacturers administering drugtests measured the effec-
tiveness of the program.
5. The research question addressingthe drug abuse
assistance programs and servicesmanufacturing companies
provided their employees.
The subsequent discussion ofresults considers the
findings as they pertain tothe principle drug prevention
strategies utilized by Oregonmanufacturing companies.
The strategies included theuse of company drug policies,
the administration of drug tests,and the availability of
employee assistance programs.58
Testing of the Hypotheses
Based upon the industrialclassifications and size
of the manufacturingcompanies discussed inthe previous
section, the resultsof the hypothesestested for this
investigation are presented.
Hypothesis #1
There will be no statisticallysignificant
differences between companieswith drug
policies and companieswithout policies based
on industry classification.
Comparisons of whethermanufacturers used workplace
drug policies basedon industrial classificationrevealed
no significant differencesutilizing chi square analysis
( e (df= 20)= 24.77, p < .21).Because no statistically
significant differenceswere indicated, the null hypothesis
was not rejected.
Table 4.2 Comparison ofWorkplace Drug Policy Use
and Industry Classification
Industry
Drug
N
olicy
(%)
No Policy
N (%)
Chemical products 5 (100) 0 (0)
Transportation 5 (100) 0 (0)
Apparel products 2 (100) 0 (0)
Wood products 52(94.5) 3 (5.5)
Metal products 16(84.2) 3(15.8)
Electronics 12(80.0) 3(20.0)
Machinery 4(80.0) 1(20.0)
Paper products 7(77.8) 2(22.2)
Food products 16(76.2) 5(23.8)
Textile products 0 (0) 1 (100)59
Analysis of the data indicatedthat, with the exception of
textile products manufacturers,each industrial classifica-
tion had a majority ofcompanies utilizing drug policies.
The percentage of manufacturerswith policies ranged from
100 percent (chemical productscompanies, transportation
products) to 76 percent (foodproducts producers).Table
4.2 presents the prevalenceof workplace drug policies
within each industryclassification.
Hypothesis #2
There will be no statisticallysignificant
differences between companies withdrug
policies and companies withouta policy
based on organizational size.
Chi-square comparisons ofwhether manufacturers used
workplace drug policies basedon company size yielded no
statistically significant differences (x' (df= 6) = 10.77,
p < .09).Because no statistically significantdifferences
were indicated, the null hypothesiswas retained.Cross -
tabulation revealed that ineach of the four company size
categories, a majority of firmshad drug policies.Table
4.3 presents these findings.
Table 4.3 Comparison of DrugPolicy Use and
Company Size (No. of Employees)
Company Size
Drug Policy No Policy
N (%) N (%)
up to 99 12(63.2) 6(31.6)
100 - 249 54(83.1) 10(15.4)
250 499 30(93.8) 2 (6.3)
500 or more 30(90.9) 3 (9.1)60
Hypothesis #3
There will be no statisticallysignificant
differences between companiesthat conduct
drug tests and companies thatdo not test
with respect to industryclassification.
Comparisons of whethermanufacturers administered
drug tests based on industrialclassification yielded
statistically significant differences (x2 (df= 10) = 29.7,
p < .001).Consequently, the null hypothesiswas rejected.
The percentage of companies withdrug testing programs in
each industrial classificationranged from zero (textile
products) to 100 percent (transportationand apparel prod-
ucts).For each of the other categories,a majority of the
organizations administered drugtests.Table 4.4 presents
these results.
Table 4.4 Comparison of DrugTesting and Industry
Classification
Drug Testing No Testing
Industry N (%) N (%)
Apparel products 2 (100) 0 (0)
Transportation 5 (100) 0 (0)
Wood products 52(94.5) 3 (5.5)
Metal products 17(89.5) 2(10.5)
Paper products 8(88.9) 1(11.1)
Chemical prod. 5(83.3) 1(16.7)
Machinery 4(66.7) 2(33.3)
Electronics 10(66.7) 5(33.3)
Food products 15(71.4) 6(28.6)
Textile products 0 (0) 1 (100)
X2 (d= 10) = 29.70 significantat p < .0561
Hypothesis #4
There will beno statistically significant
differences between companiesthat conduct
drug testing and companiesthat do not test
with respect to organizationalsize.
Chi-square comparisons ofwhether manufacturers
administered drug testsbased on company sizerevealed
statistically significantdifferences ( e (df= 3)= 13.43,
p < .003).Because statistically significantdifferences
were indicated, the forth nullhypothesis was rejected.
Cross tabulation indicatedthat a majority of the organiza-
tions in each of the fourcompany size categories adminis-
tered drug tests (Table4.5).
Table 4.5 Comparison ofthe Use of Drug Tests
and Company Size (No. ofEmployees)
Company Size
Drug Testing No Testing
N (%) N (%)
up to 99 11(55.0) 9(45.0)
100 - 249 53(80.3) 13(19.7)
250 - 499 30(93.8) 2 (6.3)
500 or more 29(87.9) 4(12.1)
In summary, four study hypotheseswere tested for
statistically significantdifferences regarding manufactur-
ing companies' utilizationof workplace drug policiesor
drug tests based on industryclassification and size.The
first and second hypotheseswere retained because no dif-
ferences regarding drug policyusage were found based on
industry and company size.Statistically significant dif-
ferences were found regardingfirms administering drug62
tests based on industryclassification and size.Conse-
quently, the third and forthhypotheses were rejected.
The following discussionwill consider the research
questions findings pertainingto the use of workplacedrug
policies by manufacturingcompanies.
Workplace Drug Policies
A majority of the Oregonmanufacturing organizations
surveyed (83 percent) haveimplemented a formal workplace
drug policy.One of the objectives of theresearch was to
identify the issues andfactors that influenced thedeci-
sion to developor not develop a policy governingdrug use
by employees.
Research Ouestion #1
What factors or issuessupported the decision to
implement or not implementa written organiza-
tional drug policy?
Representatives of manufacturingcompanies withouta
written workplace drugpolicy (n= 21) identifieda number
of reasons why sucha policy was not used.Thirty-three
percent (n= 7) of therespondents indicated thatemployee
drug use was not considereda problem.In addition, four
respondents (19 percent) identifiedconcern for employee
privacy and the need tonegotiate with labor unionsas fac-
tors impeding the developmentof a drug policy.Finally,
two respondents (10 percent)considered employee opposition
and a possible negative impacton workforce morale as63
reasons for not implementinga policy.
For the twenty-one companieswithout a workplace
drug policy, respondentswere asked if future implementa-
tion of a policywas being considered.Less than half
(47.1 percent) of therespondents reported that their
companies were consideringadopting drug policies.
As with the precedinggroup, respondents for organi-
zations with formalworkplace drug policies (n=126) iden-
tified a number of factorsand issues contributingto the
development of such policies.As illustrated in
Table 4.6, the five factorsidentified by a majorityof
respondents as contributingto the implementation ofa drug
policy were: employee druguse, worksite accidents,concern
for public image, decliningperformance, and absenteeism.
Table 4.6 Factors Identifiedas Contributing to the
Development of a WorkplaceDrug Policy
Contributing Factors
Response (n= 126)
N (%)
Employee drug use 101 (80.2)
Worksite accidents/injuries 92 (73.0)
Concern for public image 68 (53.9)
Declining employee performance 68 (53.9)
Rising employee absenteeism 58 (46.0)
Federal government regulations 35 (27.8)
Research Question ft2
What provisions characterizedthe drug policies
that have been implementedby Oregon manufactur-
ing organizations?
Respondents representing companieswith workplace
drug policies (n= 126) identifieda number of common64
provisions outlined in thepolicies (Table 4.7).Most
manufacturers (97.1 percent) withdrug policies applied the
policy to all employees incontrast to only certainemploy-
ees.All but four respondents(96.7 percent) indicated
that their companies' policiesstipulated illicit druguse
was forbidden at the worksite.Thirty-nine (32.5 percent)
companies specified in theirpolicies that druguse was
forbidden anywhere and anytime,
Table 4.7 Drug Policy Provisions
including off-the-job.
Policy Provisions
Response(n= 126)
N (%)
Covers all employees 121 (96.0)
Drugs forbidden at worksite 118 (93.6)
Use of illicit drugs forbidden
anywhere, at all times 39 (30.9)
Policy violations willresult
in job termination 70 (55.6)
Disciplinary action for policy
violations up to, but not
including, job termination 82 (65.1)
Another common provision foundin workplace drug
policies addressed the issueof policy violations.The most
common (65 percent, n= 82)response to employees who violat-
ed the drug policywas some form of disciplinary actionup
to but not including jobtermination.Fifty-six percent of
the respondents (n= 70) indicatedthat an employee could be
terminated for violating thecompany drug policy.
Having reviewed the informationregarding the use of
workplace drug policies by manufacturingcompanies, the
discussion will now considerthe results obtained from the
research questions associated withdrug testing.65
Workplace Drug Testing
A majority of the Oregon manufacturing organizations
surveyed (81 percent) have instituted drug testingrequire-
ments for employees and/or job applicants.Identifying the
factors and issues that influenced the decisionto imple-
ment or not implement a drug testingprogram was one of the
primary goals of this investigation.
Research Question #3
What factors or issues supported the decision
to implement or not implement a drug testing
program?
Representatives of companies not requiring drug
tests (n= 28) identified a number of reasons why testing
was not used.The most frequently identified explanations
for not conducting drug tests included: (1) employeedrug
use not considered a problem (44.0 percent), (2) concern
for the validity of the testing methods (37.5 percent),
(3) testing considered an invasion of employee's privacy
(37.5 percent), and (4) possible legal challenges(36.0
percent).One fourth of the respondents for non-testing
companies indicated that the cost ofa drug testing program
(25 percent), and the possible negative impact testing
could have on employee morale (25 percent) dissuaded the
use of drug testing.Employee opposition, however, was not
identified as a contributing factor for not implementinga
testing program.66
Respondents for manufacturers conductingdrug test-
ing (n= 123) identifieda number of factors contributing to
the decision to implementa drug testing requirement.The
most common contributing factor(84 percent) identifiedwas
employee drug use.In addition, sixty-one percent (n=75)
of the respondents indicated worksiteaccidents and inju-
ries, rising Worker's Compensationclaims, and declining
employee performance levels contributedto the implementa-
tion of a drug testingprogram.
Table 4.8 Factors Identifiedas Contributing to the
Implementation of a Drug TestingProgram
Contributing Factors
Response(n= 123)
N (%)
Employee drug use 103 (83.7)
Worksite accidents/injuries 75 (61.0)
Rising Worker's Compensation 75 (61.0)
Declining employee performance 75 (61.0)
Company's public image 67 (54.5)
Rising absenteeism/sick leave 67 (54.5)
Rising insurance premiums 61 (49.6)
Mandated by the federal gov't 27 (22.0)
Concern for the company's public imageand rising
employee absenteeism and sick leaverates were identified
by sixty-seven (55.6 percent) ofthe respondents as con-
tributing to the decision to implementa drug test require-
ment.Finally, approximatelyone fifth (22 percent) of the
respondents revealed that implementinga drug testing
program had been mandated by federal governmentregula-
tions.These findings are presented inTable 4.8.67
Research Question #4
What type of drug testsare used by Oregon
manufacturers and under what circumstances
are such tests administered?
Respondents for organizations requiring drugtests
(n= 123) were queriedas to the types of drug tests util-
ized and the circumstances under whichtesting was con-
ducted.The variety of drug tests inuse were categorized
by the two groups eligible for testing:current employees
and job applicants.
Employee Drug Testing
For companies with drug detectionprograms
(n= 123), 92 percent requiredemployees to submit to test-
ing under certain circumstancesor at certain times.Of
these companies, 99 percent (n= 112) indicatedall employ-
ees were eligible for testing.One manufacturer limited
drug testing to non-management personnelonly.
The most common type of employee drug testingwas
"for cause" testing.Ninety-seven percent (n= 110) of
these manufacturers requireda person to submit to a drug
test in the event he or shewas suspected of being under
the influence of illicit drugs.Approximately 80 percent
(n= 97) of the companies utilizedincident-based testing
where by an employee involved inan accident or some other
incident potentiallyassociated with illicit druguse
could be tested.Less common forms of testingwere random,
unannounced drug tests (23 percent) andregularly scheduled
testing of all employees (11 percent).68
Pre-Hire Drug Testing
Of the 123 manufacturers withdrug detection
programs, 119 of the companies (96.7 percent)required job
applicants to submit toa drug test as a condition for
applying and/or acceptinga position.Of these companies,
96 percent (n= 117) administereddrug tests to applicants
for any company position.Three firms (3 percent) reported
conducting drug screens with applicantsfor non-management
positions only, whileone company administered drug tests
only to applicants for positions"where employee safety is
a factor."
Research Question #5
What methods and procedures characterizedthe
drug testing programs of Oregonmanufacturers?
Respondents with organizations requiringdrug tests
(n= 123) were queriedon the testing methods and procedures
used in the company drug testingprograms.
1. Drug Testing Methods.Of the various testing
methods used for drug detection,urinalysis screening by
immunoassay or radioimmunoassayrepresented the most common
form of testing (95.1 percent)administered by Oregon
manufacturers.Use of the more sophisticated urinalysis
techniques, specificallygas chromatograph and mass spec-
trometry, was reported by seventy-onepercent (n= 87) of
the companies, but only when "confirming"an initial posi-
tive test result.In addition, one fifth (19.5 percent)of
the organizations (n= 24) utilizedblood sample analysis as
a means of detecting illicit druguse.69
2. Drug Testing Program Procedures.A number of
features and procedures were found to becommon among many
of the drug testing programs within Oregon manufacturing
companies.Of the 123 companies with drug detectionpro-
grams, all but one (99 percent) contracted with commercial
laboratories for all body fluid sample analyses.
Many companies with drug testing programs utilizeda
variety of different measures to insure the security and
confidentiality of the testing.A "chain of command"
system documenting every individual involved in the testing
process was used by 83 percent (n= 102) of the manufactur-
ers.Controlling access to the results of drug tests to
insure confidentiality was practiced byevery organization
(n= 113) administering drug tests to employees.In addi-
tion to the aforementioned procedures, witnesseswere used
during the sample collection phase ofa drug test by 51
percent (n= 63) of the companies.
3. Drug Test Results.Important components of a
drug test policy are the protocols specifying the actions
taken in the event an employee's drug test indicates illic-
it drug use.Eighty-nine percent of the manufacturers
(n= 109) adhered to a policy of retestinga body fluid
sample initially testing "positive" with a more advanced
detection technique.Seventy-six percent (n= 93) of the
companies referred an individual to an employee assistance
program and/or treatment program.Approximately sixty
percent of the companies (n= 72) placed an employee ona
probationary status with periodic retesting.During the70
probation, should an employee test"positive" for illicit
drug use, employmentwas terminated.Immediate termination
of employment followingan initial positive test result was
reported by thirty-four percent (n=42) of the companies.
The least common form of disciplinaryaction (29 percent)
involved issuing an oral and/or writtenwarning to an
employee testing positive for illicitdrug use.
Companies administering drug teststo job applicants
identified the actions taken ifa job candidate tested
"positive" for illicit drugs.Ninety-three percent of the
organizations (n= 114) indicated thatthe candidate would
not be hired.Twenty-one percent of companies testingjob
applicants (n= 26) notified individualstesting positive as
to why their applicationswere rejected.Only two manufac-
turers (1.4 percent) hiredan applicant after testing posi-
tive for illicit druguse.
In addition to the aforementioned actions,seven
companies (6 percent) allowed jobcandidates testing "posi-
tive" to reapply for job openingsfollowing a specified
period of time.The time period ranged froma minimum of
30 days to 9 months, with the mostcommon time interval
being 6 months.
Research Ouestion #6
How have organizations with drug testing
programs evaluated the effectiveness of
the programs?71
Respondents for manufacturing companies withdrug
testing programs were asked whether theprograms included
provisions to measure the effectiveness ofthe testing.
Of the 123 manufacturers with testingprograms, only 39
(32 percent) collected and analyzed informationto assess
the effectiveness of the drug testing efforts.
The most common data compiled tomeasure the effec-
tiveness of a drug testingprogram were the actual test re-
sults.Approximately eighty-five percent of the companies
(n= 33) compared the rates of positive drugtests and nega-
tive test results as ameasure of program effectiveness.A
majority of companies tracked changes inthe level of
Worker's Compensation claims (80 percent), thenumber of
worksite accidents (74 percent), and therate of sick leave
(64 percent) to assess the effectiveness ofthe drug test-
ing programs.Manufacturers were least likely touse
productivity indicators (39 percent) to evaluatedrug
testing effectiveness.Table 4.9 illustrates these
results.
Table 4.9 Measuring the Effectiveness ofDrug Testing
Effectiveness Measures
Response (n= 39)
N (%)
Drug test results (pos. vs. neg.) 33 (84.6)
Worker's Compensation rates 31 (79.5)
Worksite accidents 29 (74.4)
Employee absenteeism rate 25 (64.1)
Sick leave rates 19 (48.7)
Productivity indicators 15 (38.5)72
Having reviewed the findings of the researchques-
tions associated with drug testing, the discussionwill now
consider the results pertaining to assistanceprograms and
services addressing the problem of employeedrug abuse.
Drug Related Employee Assistance Programs and Services
Seventy-five percent (n= 114) of manufacturing
companies surveyed reported providingprograms or services
designed to assist employees with drug abuseproblems.The
prevalence of these services increased to 85 percent
(n= 109) for organizations with either drug policiesor
drug testing programs.For companies with neither drug
policies or drug testing requirements (n=20), only four
provided some type of drug abuse related programmingor
service for their employees.
Research Question #7
What drug abuse related employee assistance
programs or services are organizations
providing employees?
For manufacturing companies offering anti-drugpro-
grams or services for employees (n= 114), providing health
insurance coverage for drug abuse treatmentproved to be
the most common form of assistance (92 percent).Further-
more, 71 percent (n= 81) of the companies with assistance
programs made the services available to employee family
members.
A majority of manufacturers providedsome form of
education or training addressing illicit drug abuse.73
Approximately 80 percent of the companiesreported sponsor-
ing employee drug educationprograms (n= 94) or drug relat-
ed training for supervisors andmanagers (n= 93).
Among the manufacturing companiessurveyed,
contracting with an outsideagency to provide anti-drug
services for employees was the mostcommon form of assis-
tance program.Eighty-five percent (n= 97) reported having
drug treatment referrals conducted byan outside agency,
while 68 percent (n= 77) contractedwith outside agencies
to provide employee drug counseling.In contrast, only 35
percent (n= 40) of manufacturers providedon-site drug
treatment referrals.On-site employee drug counselingwas
even less common.Only 30 percent (n= 34) of the companies
provided on-site drug counseling.Table 4.10 presents
these results.
Table 4.10 Company Sponsored Drug AbusePrograms/Services
Programs/Services
Response(n= 114)
N (%)
Employee drug education 94 (82.5)
Drug related supervisor training 93 (81.6)
On-site employee drug counseling 34 (29.8)
Contracted drug counseling services 77 (67.5)
On-site drug treatment referrals 40 (35.1)
Contracted drug treatment referrals 97 (85.1)
Services available to employee
family members 81 (71.1)
Health benefits coverage for
drug treatment 105 (92.1)74
Summary
This chapter described the studysample, reported
the results as they pertainedto the statistical analysis
of the four null hypotheses, and summarizedthe information
provided by the respondents regardingtheir organizations'
anti-drug strategies.
The four study hypotheseswere tested for statisti-
cally significant differences regardingwhether manufactur-
ing companies utilized workplacedrug policies or drug
tests based on industry classificationand company size.
The first and second hypotheseswere retained because
differences were not found between companieswith drug
policies and those without when comparisonswere made based
on industry and size.Statistically significant differenc-
es were found between companies administeringdrug tests
and those not testing when comparisonswere made based on
industrial classification and size.Consequently, the
third and forth hypotheseswere rejected.
Descriptive informationwas presented with regards
to the use of drug policies, drug testing,and drug abuse
assistance programs by manufacturers.A review of the fac-
tors identified as contributing to the decisionto use or
not use a drug policy ora drug testing program were con-
sidered first.A discussion of the findings regarding the
provisions and procedures associated withdrug policies and
testing was also presented.Finally, attention was direct-
ed at the services designed to assistemployees with drug
abuse problems.75
CHAPTER V
DISCUSSION, CONCLUSIONS, AND RECOMMENDATIONS
Discussion
This chapter provides a discussion regarding the
analysis of the information compiled for this study,pres-
ents conclusions based on these findings, and offersrecom-
mendations for further research.The discussion has been
organized into three segments corresponding to the three
common workplace drug prevention strategies: a written
company drug policy, drug testing, and employee assistance
programs providing drug abuse related services.
The first section considers the prevalence of work-
place drug policies among Oregon manufacturing companies.
This is followed by a discussion of drug testing and the
different aspects of the testing programs used by the
manufacturers.Finally, attention is directed at the
prevalence of employee assistance services and education
programs addressing the problem of employee drug abuse.
Workplace Drug Policies
A majority (83 percent) of the 152 Oregon manufac-
turing companies surveyed have adopted a written workplace
drug policy.This finding represented a slightly higher76
prevalence level than what has been reportedby various
national surveys (Axel, 1990; Feuer,1987; McNabb, 1990).
According to the literature, theuse of company drug
policies has been linked to the size ofan organization as
defined by the number of employees (Feuer,1987; U.S.
Department of Labor, 1989).Feuer's (1987) study of 2,400
companies found 80 percent of businesses with10,000 or
more employees with drug policies, as compared to60 per-
cent of firms less than a 100 workers.The U.S. Department
of Labor Bureau of Labor Statistics (1989)survey of 7,500
business establishments reported only 6percent of the
establishments with 10 or fewer employeeshad formal poli-
cies, compared with 83 percent of those withover 5,000.
Results of the investigation of Oregon manufacturers
found no significant differences between organizationswith
drug policies and those without policieswhen comparisons
were made based on company size.Although previous
research suggested that differences in theuse of drug
policies were related to organizational size,the findings
of this study did not support this.For the four company
size categories used in this investigation (i.e.,under
100, 100 to 249, 250 to 499, 500or more), a majority of
manufacturers reported having drug policies.
Factors Associated with Drug Policy Development
One of the objectives of this investigationwas to
identify those issues and factors that appearedto77
influence the decision by Oregon manufacturers todevelop
or not develop written drug policies.
Organizations without Drug Policies
Fewer than 14 percent of the manufacturing firms
surveyed did not have a written drug policy for their
employees.The most common explanation (44 percent) for
why such a policy had not been implementedwas the belief
that drug use among employees was nota problem.According
to this rationale, employees either didn'tuse illicit
drugs or used them in such a way that theusage did not
interfere with job performance.Schreier (1987) character-
ized this attitude as a "head-in-the-sand" form of denial,
given the body of evidence showing the prevalence ofdrug
use among working adults and linking usage to diminished
job skills.Whether employees not using illicit drugs
reflected the actual situations of the respondents'compa-
nies could not be determined basedon the information
provided in the investigation.
Other factors identified as deterring the develop-
ment of a workplace drug policy were legal issues.Specif-
ically, respondents (12 percent) suggested drug policies
represented an interference in an employee's right to
privacy.This perception has been reported by other
researchers: Axel (1990), Schreier (1987), and Riley (1991)
indicated that concern for legal issues precludedsome
companies surveyed from developing a drug policy.78
Organizations witb,_Drug Policies
Approximately 83 percent of the Oregonmanufacturing
companies surveyed were found to havea written workplace
drug policy.The most common (80 percent)reason provided
by respondents for such a policywas concern for employee
drug use.This finding collaborated what hasbeen reported
in the research literature (Schreier,1987; Masters et al.,
1988).Schreier (1987) asserted that employers'concerns
for workplace drug use have increased dramaticallyduring
the past decade.Ninety-five percent of the firms in his
1986 survey (n= 60) reported confronting employeedrug use
as compared to only 36 percent in 1971.Masters et al.
(1988) reported four out of ten personneladministrators
surveyed (n= 333) characterized drug abuseas one of their
organization's top three problems.
Along with concern for employee druguse, several
job-related factors supporting the decisionto develop a
workplace drug policy were identified, including worksite
accidents and injuries (73 percent), decliningperformance
levels (54 percent), and rising employee absenteeism(46
percent).In addition, 28 percent of the respondents
indicated federal government regulationsmandated the
development of a company drug policy.As previously dis-
cussed, the federal government's Drug-Free WorkplaceAct
required all federal contractors and grantees(any organi-
zation receiving work or grants from the government)to
implement a workplace drug policy(Kiell, 1990).Whether79
these manufacturers were fulfilling federalgovernment con-
tracts could not be determined from the informationprovid-
ed in the survey.
Drug Policy Provisions
Workplace drug policies have been characterizedas
articulating a company's stand against illicitdrug use,
defining the parameters ofa policy's coverage, and outlin-
ing the consequences for not abiding to theterms of the
policy (Banta & Tennant, 1989; Thompson, 1990).Although
the ban of illicit drugs in the workplace hasbeen
described as a universal feature ofcompany drug policies,
some organizations have extended the sanction beyond the
worksite to include off-work hours.The Conference Board
(Axel, 1990) reported one fourth of the companies with
policies surveyed prohibited druguse at all times.For
the Oregon manufacturers surveyed, 31 percent hadsuch a
provision as part of their workplace drug policy.
Provisions for policy violations are found inmany
workplace drug policies.According to the literature,
common actions taken in the event an employee violateda
company drug policy included: 1) disciplinary action short
of termination (e.g., a written and/or oral warning, tempo-
rary suspension from work), 2) immediate termination of
employment, and 3) referral to an employee assistance
program (Axel, 1990; Schreier, 1987).For Oregon
manufacturers, over 65 percent took some form of disciplin-80
ary action short of termination againstan employee who
violated the drug policy.In addition, 56 percent of the
firms indicated an employee couldbe terminated as a result
of policy violations.Details of the specific disciplinary
actions taken were not identified inthis investigation.
Also lacking was a measure of theprevalence of manufactur-
ers that referred policy violators to theiremployee assis-
tance programs.Indirect evidence suggestedmany companies
included EAP referralsas one response to policy viola-
tions.As discussed in Chapter 4,over 75 percent of
Oregon manufacturers had employee assistanceprograms
providing drug abuse related services.For organizations
with drug testingprograms, 85 percent referred employees
who tested positive for drugs to EAPservices.Based on
these findings, it could be suggestedthat some of manu-
facturers with drug policies wouldrefer policy violators
to employee assistanceprograms.
Drug Testing
A majority of Oregon manufacturing companies(81
percent) surveyed reported administeringdrug tests to
employees and/or job applicants.The prominence of drug
testing in the state's manufacturingsector was greater in
comparison to the general UnitedState's business community
as reported by various national surveys (Axel,1990).
Studies have reported the prevalenceof drug testing to
range from 25 to 76 percent of companies surveyed(see Axel81
(1990) for a summary of published surveys).The variance
in survey findings could be attributedto the different
study samples, specifically with regardsto the types of
industries surveyed, and the size of thecompanies (Axel,
1990; Greenberg, 1990).
One factor associated with the prevalence ofwork-
place drug testing has been the size of companiesas
defined by the number of employees (Axel,1990).Research-
ers have suggested the larger the organizations, themore
likely drug testing programsare used (Axel, 1990; U.S.
Department of Labor, 1989).Results from the investigation
of Oregon manufacturers indicated differencesbetween
companies with testing programs and thosewithout programs
were significant when comparisons were made basedon compa-
ny size.Eighty percent of the manufacturers with100 to
250 employees administered drug tests, while91 percent of
the companies with 250 or more reported usingdrug testing.
The greatest percentage of firms testingfor illicit drug
use (94 percent) had between 250 and 499 employees.By
comparison, 55 percent of the businesses withless than 100
employees reported having a drug test requirement.
The results of the investigation also demonstrated
that significant differences were present betweenmanufac-
turers with testing programs and those withoutprograms
when comparisons were made basedon industry classifica-
tion.Comparisons were based on the federal government's
standard industry classifications for manufacturers.82
Because the literature as reported comparative research
based on general industries (i.e., manufacturers compared
with retailers, finance/insurers, and utilities) andthe
use of drug tests, the results of this investigation could
not be compared with the national findings.
Conditions Influencing the Decision to use Drug Testing
One of the objectives of this investigation was to
identify those issues and factors that influenced the deci-
sion to implement or not implement a drug testingprogram.
Organizations without Drug Testing Programs
Approximately 18 percent of the Oregon manufacturing
firms surveyed did not have a drug testingprogram.The
most common reason (44 percent) provided for not utilizing
drug tests was the belief that drug use among employeeswas
not a problem.Given the body of evidence demonstrating
the prevalence of drug usage among working adults, the
validity of such a rationale could be questioned.Whether
this explanation reflected the actual experience of the
respondents' companies could not be determined basedon the
information provided for this investigation.
Respondents also expressed reservations pertaining
to the drug testing process itself.Specifically, concern
was expressed regarding the validity and reliability of the
testing methods (38 percent), and the financial cost of
implementing a testing program (30 percent).Whether these83
considerations were based on specific knowledge (e.g.,the
average cost of collecting and analyzing a body fluid
sample), or respondent's personal opinions could not be
determined from the information provided.For many firms,
the costs of administrating drug tests could representa
considerable expense.Greenberg (1990) reported that the
average annual cost of conducting drug testing for compa-
nies ranged from $9,000 to $30,000.
Legal considerations also contributed to the deci-
sion by some manufacturers to not adopta drug testing
strategy.Respondents (36 percent) identified potential
legal actions challenging either the drug test requirement
or some aspect of the testing process as deterring the
implementation of drug screenings.Although judicial court
decisions have upheld the legality of administering drug
tests (Carrell & Heavrin, 1990), the potentially high costs
associated with legal actions may have discouragedsome
organizations from implementing a screeningprogram.In
addition, close to 40 percent of the respondents considered
testing to be a violation of an individual's rightto
privacy.Whether this perception represented the personal
belief of the individual respondentor the corporate cul-
ture of the company was not measured.Regardless, the
privacy issue was identified as contributing to the deci-
sion to not use drug testing.84
Organizations with Drug Testing Programs
Approximately 84 percent of the respondents for
companies with drug testing programs indicatedconcern for
employee drug use represented the most compellingreason
for implementing such a program.Although information
regarding specific incidences of employee druguse was not
collected for this investigation, researchers have observed
that such events often precede the introduction of drug
testing into a workplace (Axel, 1990).Marshall (1989)
described how just one week after ruling out drug testing
because of privacy concerns, a company CEO discovereda
manager unconscious as a result of cocaine use.Reversing
his earlier decision, the CEO instituteda drug testing re-
quirement beginning with himself and all seniormanagers.
After concern for drug usage in the workplace, the
most common reasons provided for implementing drug testing
pertained to job-related factors.Increased rates in
worksite accidents and injuries (61 percent), absenteeism
(55 percent), and Worker's Compensation claims (61 percent)
were identified as contributing to the use of drug testing.
Whether these factors had been directly attributed to
employee drug use in the respondents' companieswas not
indicated.
Finally, a majority of respondents (54 percent)
reported concern for the public image of their companies
contributed to the decision to implement a drug testing
program.Testing proponents have argued that workplace85
drug screening sends an important signal "into the communi-
ty that [a] company will not tolerate drugs in the work-
place and that drug users will not be hired" (Axel, 1990,
p. 18).Whether this rationale represented the attitude of
the respondents was not indicated.
When Drug Testing Occurs
Generally, drug tests are administered as part of
the pre-hiring process for job applicants and to employees.
Employees may have to submit to a drug test as a condition
of their job position or when there is a suspicion of
impairment due to drug use (Cowan, 1987; Potter & Orfali,
1990; Thompson, 1990).
Pre-employment Drug Testina
Almost every Oregon manufacturer with a drug testing
program (97 percent) required drug screens for job appli-
cants.This level of pre-employment drug testing was
slightly higher than what had been reported in the litera-
ture (Axel, 1990; Greenberg, 1990).
With few exceptions, manufacturers administered drug
tests as part of the applicant screening process for all
company positions (four companies limited pre-employment
testing to only certain job categories).One aspect of
pre-employment testing not considered in this investigation
was at what point in the application process was a drug
test actually administered.The literature has reported86
most pre-hire testing to be limited to job candidates
considered "finalists" for a position, or requiredas a
condition of employment once the job offer had been made
(Axel, 1990; Cowan, 1987; Rosen, 1987).Such a differen-
tiation was not provided in this study.
Employee Drug Testing
Ninety-two percent of the manufacturers with drug
screening programs required employees to submit to drug
tests under certain circumstances.How and when employees
would were administered drug tests depended on the type of
screening being conducted.
"For Cause" Testing
Employee drug testing triggered by conditions or
events has characterized the "for cause" type of screening
(Cowan, 1987; Carrell & Heavrin, 1990).This type of test-
ing was the most prevalent (97 percent) form of employee
screening administered by manufacturing companies.The
literature indicated "for cause" testing was the most
widely used form of employee drug screening (Axel, 1990;
Greenberg, 1988, 1989, 1990; Masi, 1987; Schreier, 1987).
A critical component of the "for cause" type of drug
test involves the role of supervisory personnel.As previ-
ously discussed, this type of testing can be triggered by a
supervisor who has observed and documented an employee's
behaviors or physical symptoms attributable to illicit drug
use (Gray & Stein, 1988; Kiell, 1990).For this testing87
criteria to be effective, managers and supervisors must be
trained not only to recognize the symptoms of drug abuse,
but also to systematically observe employees' behaviors so
that changes can be documented (Gray & Stein, 1988).
For manufacturers utilizing "for cause" drug test-
ing, 89 percent reported providing training for their
supervisory personnel.The significance of this finding
was the 11 percent that did not train supervisors and
managers.Not only does this deficiency reduce the effec-
tiveness of the drug testing strategy, it opens a company
to potential expensive litigation and liabilities should
someone challenge the legality of the testing (Crown &
Rosse, 1988).
Random Drug Testing
For manufacturers with drug testing programs,
only 23 percent administered random tests to employees.
The job categories of employees eligible for random drug
tests were not identified in this investigation.However,
because the Oregon State Employment Division (1990) charac-
terized random drug testing as appropriate only for jobs
involving public and/or workplace safety, it could be
assumed that Oregon manufacturers restrict such testing to
employees in positions involving safety.
Consequences of Positive Drug Test Results
Other important issues related to conducting drug
tests are the policies guiding the responses to positive88
test results.Specifically, what actions were taken in the
event a job applicant or an employee tested positive for
illicit drug use.
Pre-employment Screening
If a job applicant with an Oregon manufacturing
company tested positive for illicit drug use, that individ-
ual had little chance of getting hired.Ninety-seven
percent of the organizations administering drug tests to
job applicants did not hire individuals who tested positive
for drug use, even if they met all other selection crite-
ria.In addition, only 20 percent of the firms notified
the applicants of the test results.For the two companies
that indicated a "positive" drug test applicant could be
hired, the new hire would be referred immediately to the
employee assistance program.
Employees: Assist, Discipline, or Discharge?
In the event an employee tested positive for illicit
drug use, the most common action taken (76 percent) was
referring that individual to the employee assistancepro-
gram or similar service.According to Thompson (1990), the
rationale for assisting employees is that experienced
employees are a company investment that can be difficult
and expensive to replace.Helping the troubled employee
can prove to be less expensive than having to hire and
train a replacement (Thompson, 1990).In addition to
referring employees for assistance, a majority of the89
manufacturers (60 percent) placed an employee on a proba-
tionary status with periodic retesting.In this way,
companies were perhaps attempting to insure that an employ-
ee stayed "clean" after receiving drug counseling and/or
treatment.
Despite the commitment to assist employees who used
illegal drugs, 34 percent of the manufacturers reserved the
right to immediately terminate anyone testing positive for
drug use.How companies determined which course of action
was followed in response to positive test results was not
assessed in this investigation.
Evaluating Drug Testing Effectiveness
Although much has been written regarding the effec-
tiveness of drug testing in reducing the incidence of drug
abuse in the workplace, little attention has been directed
at how companies are evaluating their screening programs.
Oregon manufacturers administering drug tests to employees
and/or job applicants identified a number of factors
prompting the implementation of testing, including the
prevalence of employee drug use, increased worksite acci-
dents and injuries, and employee absenteeism.Given that
many manufacturers have developed testing programs in order
to affect change within the workplace, this investigation
sought to determine how these companies assessed whether
the desired changes were being realized.90
For companies administering drug tests, only 32
percent systematically collected and analyzed information
to evaluate the effectiveness of their drug screeningpro-
grams.The most common sources of information collectedas
part of the evaluation process included: 1) the testre-
sults, i.e., the number of negative and positivescreens
(85 percent), 2) the level of Worker's Compensation claims
(80 percent), and 3) the rate of on-the-job accidents (74
percent).To a lesser extent, employee absenteeism (64
percent) and sick leave rates (49 percent)were also uti-
lized as measures of drug testing effectiveness.
The significance of these findings was that most
companies did not attempt to evaluate their drug testing
programs.Considering the expense and controversial nature
of workplace drug testing, it is surprisingmore manufac-
turers were not assessing the effectiveness of their test-
ing programs.
Employee Assistance Programs
Approximately 75 percent of Oregon manufacturing
companies surveyed had an Employee Assistance Program
and/or services designed to assist individuals using illic-
it drugs.For manufacturers with workplace drug policies
or drug testing programs, the prevalence of drug abuse
services increased to 85 percent.When compared with what
had been reported in the literature, the level of commit-
ment by Oregon manufacturers to assist employees who used91
illicit drugs appeared to exceed what many largecorpora-
tions are providing (Axel, 1990; Greenberg, 1990).
Employee Assistance Programs Services
Employee Assistance Programs (EAPs) are generally
classified as either internal or external as defined by how
services are provided (Duda, 1990; Masi, 1984).Of the two
EAP models, external EAPs are the most common (Duda, 1990).
This type of program proved to be the most prevalent type
of EAP among Oregon manufacturers as well.Approximately
70 percent of the companies contracted their EAP services
with outside providers, as compared to 35 percent of the
firms with internal programs.Regardless of the EAP model,
manufacturers provided a range of drug assistance services,
including drug counseling, treatment referrals, and work-
force training and education.
Counseling/Drug Treatment Referral
A majority of manufacturers (68 percent) provided
drug counseling for their workforce through an Employee
Assistance Program.In addition, 85 percent included drug
treatment referrals as one of the functions of the company
EAP.An important consideration relating to an employee
participating in a drug treatment program is the cost.For
the manufacturing firms with EAPs, 92 percent offered
health insurance coverage for drug abuse treatment.Anoth-
er factor associated with effective rehabilitation of the92
individual with a drug abuse problem is including family
members in the treatment process (Kinnan, 1990).Research
has suggested that rehabilitation of chemically dependent
individuals is more successful if family members can be
treated as well (Kinnan, 1990).Perhaps for this reason,
71 percent of the manufacturers reported making their EAP
services available to employee family members.
Employee Drug Education
In addition to providing counseling and treatment
referrals, many EAPs provided drug education programs for
employees (Masi, 1984; Thompson, 1990).The increased
prevalence of these educational efforts suggests "companies
are learning... An ounce of prevention- in the form of
education on the dangers of drug abuse to health and
safety- is worth a pound of cure" (Greenberg, 1990, p. 26).
The American Management Association's (AMA) annual poll of
human resource managers has chronicled the rise of employee
drug education programs in U.S. companies (Masi, 1987;
Greenberg, 1988, 1989, 1990).The prevalence of workplace
drug education among AMA member companies increased from 21
percent in 1986 to 35 percent in 1990 (Greenberg, 1991).
Oregon manufacturing companies were found to have a
higher level of sponsorship of drug education and awareness
programs than what has been reported in the literature
(Axel, 1990; Greenberg, 1990).Eighty-three percent of
manufacturers provided drug education for their employees.
Among companies with drug policies or drug testing pro-93
grams, 95 percent of the firms sponsored employee drug
education programs.
Supervisor Training
According to Thompson (1990), an employee assistance
program can not be successful unless supervisory personnel
understand their role relative to the program.Supervisors
play an important role in identifying and directing drug
users to an assistance program and services.For a work-
place drug prevention program to work, supervisors must be
trained to recognize the relationship between job perfor-
mance deterioration and illicit drug abuse (Masi, 1984).
Most Oregon manufacturing companies with EAPs (82 percent)
reported providing drug related supervisor training.
Companies not training their management staff could be
limiting the effectiveness of their drug prevention
efforts.
Supervisors also play a critical role in a "for
cause" testing program.Administering drug tests to
employees based on a "reasonable suspicion" that job per-
formance has been impaired from illicit drug use are usual-
ly initiated by supervisory personnel (Cowan, 1987;
Thompson, 1990).Consequently, supervisors require train-
ing in order to recognize symptoms of drug abuse as they
relate to job performance (Thompson, 1990).
Among Oregon manufacturing companies with testing
programs, "for cause" testing represented the most common
type of drug screen.A majority of these firms (89 per-94
cent) provided supervisor training throughtheir employee
assistance programs.The significance of this findingwas
that it suggested over 10 percent of the organizations
utilizing "for cause" testing did not trainthe personnel
responsible for initiating sucha drug test.As discussed
earlier, such companies could be riskinglegal challenges
and even legal liabilities (Crown &Rosse, 1988).
Conclusions
The following conclusions were drawn from thefind-
ings reviewed in this chapter.First, a majority of Oregon
manufacturing companies (83 percent) hada written work-
place drug policy.Differences between organizations with
drug policies and those without policieswere not signifi-
cant when comparisons were made basedon company size and
industry classification.In addition, the development of
drug policies was influenced bya number of factors, nota-
bly employee drug use and job-related accidentsand inju-
ries.Companies without policies deemed themunnecessary
because employee drug use was not considereda problem.
The second conclusion was thata majority of manu-
facturers (81 percent) used drug testingas part of their
drug prevention programs.Differences between organiza-
tions with drug testing programs and those withoutsuch
programs were significant when comparisonswere made based
on company size and industry classification.Larger compa-
nies were more likely to use drug testingthan smaller95
companies.In addition, businesses producing wood, paper,
metal, chemical, or electronic products were more likely
to administer drug tests than those producing textiles,
machinery, or food products.
Third, more manufacturing companies with drug test-
ing programs screened job applicants (97 percent) for
illicit drugs than employees (92 percent).Generally,
if an applicant tested positive for illicit drug use, he
or she was not hired.For employees, "for cause" testing
represented the most common (97 percent) type of drug test.
Few organizations used random drug testing or regularly
scheduled universal drug tests.Should an employee test
positive for drug use, most companies (76 percent) would
refer the individual to the employee assistance program.
Thirty-four percent of the businesses indicated an employee
could be terminated immediately for testing positive.
Another conclusion was that most manufacturers
administering drug tests were not measuring the effective-
ness of their programs.Companies that evaluated their
drug screening efforts (32 percent) assessed changes in
the testing results (e.g., the number of positive test
results), and variations in the employee accident, absent-
eeism, and sick-leave rates.
Finally, most manufacturers (75 percent) had employ-
ee assistance programs that provided drug abuse related
services.Services included drug counseling, treatment
referrals, drug education, and supervisor training.96
Recommendations
The following recommendations recognize the need for
further research in the area of workplace drug prevention.
1.The findings of this investigation were specific to
Oregon manufacturing companies, and thus can not be
generalized to the State's business community.Add-
itional research should examine the workplace drug
prevention strategies being utilized within Oregon's
industrial sector.
2.Although this investigation did not consider the issue
of alcohol abuse, the literature has suggested such
abuse represents a greater problem to industry than
illicit drug use (Banta & Tennant, 1989; Campbell &
Graham, 1988).Research into whether the State's
businesses include alcohol abuse prevention as part
of their workplace substance abuse programs should be
conducted.
3.The literature has suggested that some workers perceive
drug testing to represent a form of harassment and an
invasion of privacy (O'Keefe, 1987; Vodanovich & Reyna,
1988).Reduced job performance and morale have been
attributed to the introduction of drug testing in some
companies (Vodanovich & Reyna, 1988).Research should
consider the perceptions of the Oregon workforce with
regards to workplace drug testing.97
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coverage. Personnel Administrator, 31(12), 68-76.APPENDIXORGANIZATIONAL RESPONSE TO EMPLOYEE SUBSTANCE ABUSE SURVEY
1.Does your organization have a written drug abuse policy for employees? (Circleone number)
1YES (Skip to Question 2)
2DON'T KNOW (Skip to Question 2)
3NO
102
la.Please indicate whether or not each of the following is a reason vAlyyour organization does not
currently have a written drug policy.(Circle one numberfor each reason)
YES, A NOT A
REASON REASON
DON'T
KNOW
a.Employee drug use isn't considered a problem.. . 1 2 3
b.Potential negative impact on employee morale. . 1 2 3
c. Employee/Union opposition 1
1
1
2
2
2
3
3
3
d.Such a policy would be an unwarranted
invasion of employees' privacy
e.It's inappropriate for a company to be concerned
about what employees do on their own time.
f.Adoption of a policy is currently being considered 1 2 3
g.Other: 1 2 3
(PLEASE SKIP TO QUESTION 4)
2.Please indicate whether or not each of the following was a factor in the decisionto implement an
organizational drug policy.(Circle one number for each factor)
YES, A
FACTOR
NOT A
FACTOR
DON'T
KNOW
a.Rising employee absenteeism 1 2 3
b.Unsatisfactory employee performance 1 2 3
c.Suspected/confirmed incidence of employee drug use.. 1 2 3
d.On-site accidents/injuries 1 2 3
e.Employee crimes (thefts, etc.) 1 2 3
f.Required by federal law 1 2 3
g.Concern for company's public image 1 2 3
h.Other. 1 2 3
3.Please indicate which of the following features characterizeyour organization's employee drug policy.
(Circle one number for each)
YES NO
DON'T
KNOW
a.All employees are covered by the drug policy 1 2 3
b.Some employee groups are covered by the drug policy 1 2 3
c.
d.
Employees are required to refrain from using drugs whileat work 1 2 3
Employees are required to refrain from using drugs at all
times, including away from the workplace 1 2 3
e.
f.
Employees who violate the drug policy will be terminated.. .
Some form of disciplinary action short of termination will be
1 2 3
taken against employees who violate the drug policy.. 1 2 3
g.No action will be taken against employees who violate the policy 1 2 3
h.Other: 1 2 3103
4.Does your organization provide for a formal program to help employees with drug problems?
1NO (Skip to Question 5)
2DON'T KNOW (Skip to Question 5)
3'YES
L.4a.Please indicate whether or not each of the following is/are part of your organization's effort to
assist employees with drug problems?(Circle one for each) DON'T
YES NO KNOW
a.Drug education or drug awareness programs 1 2
b.Company personnel who provide assessment/intervention
KN
services to identify employees with drug problems 1 2 3
c.Counseling services available on-site to assist employees and
make referrals to treatment programs when necessary 1 2 3
d.Drug counseling services contracted with an outside firm/agency... 1 2 3
e.Drug treatment referral services provided by an outside firm/agency . 1 2 3
f.Drug-related programs are available to employees' family members. . 1 2 3
g.Drug-related programs and services are covered by employee's
health benefits 1 2 3
h.Other 1 2 3
DRUG TESTING
In this section, we are asking for information regarding the issue of workplace drug testing.Please take a
moment to answer the following questions.
5.Does your organization currently have a formal drug testing program? (Circle one number)
1YES (Skip to Question 6)
2DON'T KNOW (Skip to Question 6)
3NO
Please indicate whether or not each of the following is reason why your organization has chosen not to L5a.
implement a drug testing program at this time.(Circle one number for each)
YES, A NOT A DON'T
REASON REASON KNOW
a.Employee drug use not considered to be a problem 1 2 3
b.Potential negative impact on employee morale 1 2 3
c.Employee/Union opposition 1 2 3
d.Concern for potential legal challenges 1 2 3
e.Costs of testing. 1 2 3
f.Concern for validity of testing methods (e.g., "false positive") 1 2 3
g.Testing represents an invasion of employee's privacy 1 2 3
h.Other: 1 2 3
5b.Is your organization presently considering the implementation of an employee drug testing program?
1YES
2NO
3DON'T KNOW
(PLEASE SKIP TO QUESTION 17)104
6.When was your organization's drug testing program implemented? (Circle one number)
1PRIOR TO 1980
21980 - 1983
31984 - 1987
41988 - PRESENT
7.Which of the following employee group(s) may be tested for drugs?(Circle one number)
1ALL EMPLOYEES
2MANAGEMENT ONLY
3NON-MANAGEMENT ONLY
4NONE
5DON'T KNOW
8.Which of the following job applicant group(s) may be tested for drugs?(Circle one number)
1ALL JOB APPLICANTS
2APPLICANTS FOR MANAGEMENT POSITIONS ONLY
3APPLICANTS FOR NON-MANAGEMENT POSITIONS ONLY
4NONE
5DON'T KNOW
9.Please indicate which of the following features characterize your organization's testing policy.
(Circle one number for each) DON'T
YES NO KNOW
a.Pre-hire screening of job applicants 1 2 3
b.Random, unannounced testing of selected employees 1 2 3
c.Periodic announced testing of all employees 1 2 3
d.Incident-based testing (e.g., after an accident) 1 2 3
e."Reasonable cause' testing (i.e., suspected or alleged drug use) . 1 2 3
f.Supervisors are trained in identifying drug use 1 2 3
g.Other: 1 2 3
10.Please indicate whether or not each of the following was a factor in the decision to implement a drug testing
program. (Circle one number for each factor) YES, A
FACTOR
NOT A
FACTOR
DON'T
KNOW
a.Suspected/Confirmed incidence of employee drug use 1 2 3
b.Drug related accidents/injuries 1 2 3
c.Drug related employee theft or other crimes 1 2 3
d.Unsatisfactory employee performance 1 2 3
e.Rising employee absenteeism/sick leave 1 2 3
f.Rising Worker's Compensation claims 1 2 3
g.Rising insurance premiums 1 2 3
h.Testing required by federal law 1 2 3
i.Company's public image 1 2 3
j.Industry recommendations 1 2 3
k.Other 1 2 3105
11.What is the estimated annual cost of the drug testing program for your organization's Oregon-based
manufacturing operation?(Circle one number)
1LESS THAN $1,000
2$1,001 - S4,999
3S5,0013 OR OVER
4DON'T KNOW
12.Please indicate which of the following features characterize your organization's drug testing program.
(Circle one number for each)
YES NO
DON'T
KNOW
a.Analysis of samples contracted with a commercial lab 1 2 3
b.Lab is certified by the federal government to perform drug testing1 2 3
c.Sample collection is witnessed to prevent cheating or tampering..1 2 3
d.
e.
Access to test results controlled to insure confidentiality
Documentation procedures that identify every individual
1 2 3
involved in the processing and testing of a sample 1 2 3
f.Individuals tested are provided with a copy of the lab report . 1 2 3
g.Positive test results are confirmed with more sophisticated tests 1 2 3
h.Other: 1 2 3
13.Please indicate whether or not the following testing methods are used as part of your organization's strategy
to prevent drug abuse? (Circle one number for each one) YES,
USED
NOT
USED
DON'T
KNOW
a.Urinalysis screening tests (Immunoassay, Radioimmunoassay) 1 2 3
b.Confirmation tests (Gas Chromatograph, Mass Spectrometry) 1 2 3
c.Blood sample analysis 1 2 3
d.Psychological testing (e.g., "honesty tests") 1 2 3
e.Polygraph analysis (i.e., 'lie detector") 1 2 3
f.Other: 1 2 3
14.If a prospective employee has met all of the basic job selection criteria, and fails a drug test, which of the
following would describe the action that would be taken? (Circle one number)
1REJECT CANDIDATE AND COMMUNICATE REASON
2REJECT CANDIDATE WITHOUT COMMUNICATING TEST RESULTS
3HIRE CANDIDATE ON CONDITION OF TREATMENT/REFERRAL
4HIRE CANDIDATE ON CONDITION OF PERIODIC REI h.STING
5HIRE CANDIDATE WITH NO ACTION TAKEN
6OTHER:
15.If a current employee tests positive for drugs, indicate whether or not each of the following actions would
be taken (Circle one number for each action)
YES NO
DON'T
KNOW
a.An automatic re-test 1 2 3
b.A second, more advanced test procedure 1 2 3
c.Oral/Written warning 1 2 3
d.Immediate termination of employment 1 2 3
e.Referral to a treatment or employee assistance program 1 2 3
f.Placed on a probationary status with periodic retesting 1 2 3
g.Other: 1 2 316.Has your organization established a system to collect and analyze information in order to measure the
effectiveness of the drug testing program? (Circle one number)
1NO (Skip to Question 17)
2DON'T KNOW (Skip to Question 17)
3YES
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L16a. Please indicate whether or not each of the following information are used as criteria to measure the
effectiveness of the drug testing program.(Circle one number foreach source)
YES, NOT
USEDUSED
DON'T
KNOW
a.Drug testing results (i.e., rate of positive/negative results) . 1 2 3
b.Productivity indicators 1 2 3
c.Absenteeism rates 1 2 3
d.Employee sick leave levels 1 2 3
e.Worker's Compensation claims 1 2 3
f.Frequency of accidents/injuries 1 2 3 ---------------
g.Cost-Benefit analysis 1 2 3
h.Employee feedback 1 2 3
i.Other: 1 2 3
BIOGRAPHICAL INFORMATION
In this final section, we are asking for some general information regarding you and your organization to help us in
our statistical analysis. Be assured that the information collected will be held in confidence and that neither you
or your organization will be identified.
17.Please describe your occupation/position:
18.What is your organization's principle business or industry?(Circle one number)
1LUMBER AND WOOD PRODUCTS 2PAPER & APPLIED PRODUCTS
3CHEMICAL & ALLIED PRODUCTS 4MACHINERY (except electrical)
5ELECTRONICS, FT FCTRICAL 6METAL PRODUCTS
7TRANSPORTATION EQUIPMENT 8TEXTILE PRODUCTS
9APPAREL PRODUCTS 10FOOD PRODUCTS
11OTHER:
19.Approximately how many employees does your organization employ within Oregon? (Circle one number)
1UP TO 99
2100 - 249
3250 - 499
4OVER 500
THANK YOU FOR YOUR PARTICIPATION AND COOPERATION.